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ABSTRACT
EFFECTS OF HZE IRRADIATION ON CHEMICAL NEUROTRANSMISSION
IN RODENT HIPPOCAMPUS
Mayumi Machida
Eastern Virginia Medical School, 2009
Director: Dr. Gyorgy Lonart

Space radiation represents a significant risk to the CNS (central nervous system)
during space missions. Most harmful are the HZE (high mass, highly charged (Z), high
energy) particles, e.g. 56Fe, which possess high ionizing ability, dense energy deposition
pattern, and high penetrance.
Accumulating evidence suggests that radiation has significant impact on cognitive
functions. In ground-base experiments, HZE radiation induces pronounced deficits in
hippocampus dependent learning and memory in rodents. However, the mechanisms
underlying these impairments are mostly unknown.
Exposure to HZE radiation elevates the level of oxidation, resulting in cell loss,
tissue damage and functional deficits through direct ionization and generation of reactive
oxygen species (ROS). When hippocampal slices were exposed to ROS, neuronal
excitability was reduced. My preliminary results showed enhanced radio-vulnerability of
the hippocampus and reduction in basal and depolarization-evoked [ H]-norepinephrine
release after HZE exposure. These results raised the possibility that HZE radiation
deteriorates cognitive function through radiation-induced impairments in hippocampal
chemical neurotransmission, the hypothesis of this dissertation.
In Aim 1 I have focused on the effects of HZE radiation on release of major
neurotransmitter systems in the hippocampus. I have further extended my research on the

levels of receptors of these systems in Aim 2. In Aim 3, I have studied the level of
oxidation in membranes of my samples.
My research reveals that HZE radiation significantly reduces hyperosmotic
sucrose evoked [3H]-glutamate and [14C]-GABA release both three and six months post
irradiation. The same radiation regimen also significantly enhances oxidative stress as
indicated by increased levels of lipid peroxidation in the hippocampus, suggesting that
increased levels of lipid peroxidation may play a role in reduction of neurotransmitter
release. HZE radiation also significantly reduces levels of neurotransmitter receptors
critical to synaptic plasticity; glutamatergic NMDA (TV-methyl /^-aspartate) receptors and
pi adrenergic receptors, three months post irradiation. By six months post irradiation, the
levels of these receptors are returned to normal, implying that partial repair may take
place.
My findings demonstrate that a single dose of HZE radiation alters the
neurochemical environment in the hippocampus, which may underlie radiation-induced
cognitive dysfunction.
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CHAPTER I
INTRODUCTION

INTRODUCTION TO THE PRESENT STUDY
In the 20-year Strategic Program Plan (SPP) for Space Radiation Health Research
(SRHR), NASA has identified four major health concerns regarding exposure to space
HZE (high mass, highly charged (Z), high energy) radiation; 1) acute radiation
syndromes, 2) degenerative tissue effects, 3) carcinogenesis, and 4) damage to the
Central Nervous System (CNS) (1). Currently, with the possible exception of cataracts,
there are no direct human data available for space radiation risk assessment (2). The CNS
risks are classified as acute and delayed radiation effects (1), and the late delayed effects
of radiation are the major concern in estimating risks to crew members (3, 4). Currently,
the following delayed risks are reported; 1) deterioration in motor function (5), 2)
behavioral impairments mediated by the dopaminergic system (6-8) and 3) cognitive
dysfunction (9, 10), with no proven mitigation strategies (2). These risks may be
enhanced by synergistic effects such as bone loss, cardiovascular alterations, and
impaired sensory-motor adaptation (1, 11). NASA plans to return humans to the Moon
by 2019 and to Mars by 2030. They have placed high priority on investigating CNS risks
(1), as CNS injury may cause severe interference with job performance during an
extended space mission to Mars. Phase 1 of this plan (2006 -2013) emphasizes the

The model journal for this dissertation is Radiation Research.
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urgent needs to; 1) develop a new risk model to reduce uncertainties regarding radiation
induced CNS damage. 2) develop experimental evidence for radiation induced CNS
damage, and 3) validate permissible exposure limits for space radiation in terms of CNS
functions (12).
Studies with conventional radiation, e.g., X-rays and y-rays, in ground based
settings have established deleterious effects of ionizing radiation on the human brain.
Long-term studies with childhood cancer survivors revealed that cranial radiation therapy
often results in progressive cognitive dysfunction (13-16). Young and adult patients of
acute lymphoblastic leukemia and brain tumors who had received cranial radiation
therapy display a delayed and progressive decline in cognitive performance including
impairments in attention, visual perceptual skills, executive function, and memory (75).
Ris and co-workers reported that brain tumor survivors had a 17.4 point decrease in full
scale intelligence quotient (IQ) four years after radiation therapy even when moderate
doses of radiation were applied (14). The neuronal mechanisms that underlie these effects
remain mostly unknown. Possible causes include demyelination suggested by quantitative
magnetic resonance imaging (MRI) studies that detected white matter necrosis (15).
Since the damage correlated with decreased attention, lower IQ and academic
achievement (16), this histopathological change has been hypothesized as a mechanistic
base for radiation induced cognitive dysfunction (13). Rodents given a 25 Gy dose of Xray radiation have been used extensively to investigate the histopathology of the
radiation-induced damage, as this dose induces vascular lesions as well as radionecrosis
that is associated with demyelination one year after irradiation (17).

3

Research on hippocampal neurogenesis has revealed that radiation may induce
cognitive impairments even at doses that are well below the threshold for producing
histopathological changes. Whole brain irradiation of mice subjected to a single mild
dose (10 Gy) of X-rays showed reduced performance in a Barnes maze, a hippocampaldependent spatial learning test (18). Since the same dose of radiation nearly abolishes the
production of new neurons in rodents one or two months post irradiation (19, 20), it has
been suggested that radiation-induced cognitive dysfunction may depend on adult
neurogenesis in the hippocampus. However, there was no correlation between radiation
induced suppression of adult neurogenesis and spatial learning tested in a different
behavioral paradigm, e.g. Morris water maze (21, 22). In addition, when other techniques
were used to suppress adult neurogenesis, they failed to establish an unambiguous link
between adult neurogenesis and learning and memory (23, 24). Thus, a causative
relationship between radiation induced suppression of neurogenesis and radiation induced
cognitive impairment still awaits clarification (24).
An alternative neuronal mechanism of radiation-induced cognitive dysfunction is
perturbation of chemical neurotransmission, a mechanism mostly independent of
neurogenesis (25). Transduction of neuronal signal may be achieved by electrical
coupling of pre- and postsynaptic elements at electrical synapses. However, the
overwhelming majority is chemical synapses, which use chemical substances for
transmission". Exposure to radiation results in the generation of toxic free radicals (26,
27) which affects neurotransmission (28-31). When a hippocampal slice preparation was
exposed to H2O2, an experimental model to assess effects of HZE radiation (28), the

In the rest of the text, the term "neurotransmission" will refer to "chemical neurotransmission".
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exposure altered neuronal excitability, the ability to generate action potentials (29), and
reduced synaptic efficacy at both inhibitory and excitatory synapses (30). H2O2 also
suppressed [K+]-depolarization-evoked [3H]-glutamate release from isolated cortical
nerve terminals, suggesting that radiation induced reactive oxygen species (ROS)
production may perturb the functional integrity of release machinery (31).
Currently neurochemical research on space HZE radiation effects has been mostly
limited to nigrostriatal dopaminergic (DA) and cholinergic neurotransmission (5, 32, 33),
a brain region mostly involved in movement coordination (34). Joseph et al found that 0.1
to 1.0 Gy of HZE radiation significantly reduced the enhancement of depolarizationevoked DA release by oxotremorine, muscarinic cholinergic receptor agonist (5). This
effect was region-specific, as decrements were observed only in the striatum but not in
the hippocampus (35).
Much less understood are the effects of space radiation on hippocampal
neurotransmission, despite the well documented HZE radiation-induced impairments in
hippocampus dependent behavior (9, 10, 36), and radio-sensitivity of the region (28, 37).
In line with these previous reports, my preliminary results also demonstrated significantly
enhanced radio-vulnerability of the hippocampus (Chapter I, Preliminary Results for a
full detail). Thus, in this study, I have focused on the effects of HZE radiation on
chemical neurotransmission in the hippocampus. My hypothesis is that HZE radiation
disrupts functional integrity of hippocampal neurotransmission, which may be a
component of radiation-induced cognitive dysfunction.

5

Since major events in synaptic neurotransmission are release of neurotransmitters
and activation of neurotransmitter receptors, I addressed possible HZE effects on these in
the following specific aims.
In Aim 1, I tested effects of HZE radiation on release of major hippocampal
neurotransmitters. I assayed basal and hyperosmotic-shock evoked release from
glutamatergic, GABAergic (y-amino-butyric acid), and noradrenergic systems
(Chapter II). Hyperosmotic sucrose evoked release has been used as a measure of the size
of the readily releasable pool, which reflects release probability (38) and synaptic
strength (39). Glutamate is the major excitatory transmitter in the CNS and the
participation of glutamatergic NMD A receptors in long-term potentiation (LTP) and
depression (LTD) provides a strong link between the glutamatergic systems and the
mechanisms of learning and memory (40). GABA is the major inhibitory transmitter in
the CNS, and behavioral/pharmacological studies have suggested that GABA receptor
blockade can improve hippocampal dependent learning and memory (41). NE is also
implicated in synaptic plasticity; a- and P-adrenergic receptor manipulations modulate
LTP in hippocampal pathways (42, 43) and learning tasks (44). My working hypothesis
was that HZE radiation perturbs release of these hippocampal neurotransmitters, which
play critical roles in hippocampal dependent learning and memory.
In Aim 2, I tested the effects of HZE radiation on levels of neurotransmitter
receptors (Table 1) by quantitative western blot analysis to elucidate biochemical
correlates of possible changes in neurotransmission (Chapter III). My working hypothesis
was that HZE radiation may affect these protein levels, and in turn these may lead to
alterations in synaptic strength, giving rise to impaired learning and memory.
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TABLE 1A
Neurotransmitter Receptors Evaluated in Quantitative Western Blot Analysis
Receptor subtype;

Mw

NMDANR1
NMDANR2A
NMDANR2B
AMPAGluRl

120kDa
170 kDa
180kDa
106 kDa

GABAA al
GABAB

50 kDa
130 kDa

al
a2A

60 kDa
45 kDa
64 kDa

Glutamatergic

GABAergic

Noradrenergic

PI

TABLE IB
Synaptic Proteins Evaluated in Quantitative Western Blot Analysis
Description

Proteins

Synaptic vesicular protein
Synaptophysin
Vesicular glutamate transporter
VGlutl
Scaffold protein for glutamatergic re
PSD-95
Microtubule associated protein
MAP2a/2b/2c

Loading control
Loading control

Actin
VCP

Mw
38 kDa
70-80kDa
95kDa
280kDa (2a, 2b), 70kDa (2c)

42 kDa
97 kDa
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Aim 3 was designed to test HZE effects on lipid peroxidation in the
hippocampus (Chapter IV). By definition, ionizing radiation generates ions, which
increase the formation of free radicals and reactive oxygen species (ROS). Imbalance
between the pro-oxidants and anti-oxidants may cause oxidative stress, e.g. oxidation of
membranes. My working hypothesis was that lipid peroxidation of membranes may
underlie impairments in hippocampal neurotransmission.
To investigate these specific aims, I exposed rats to single doses of 0.6, 1.4, 2.0
Gy of HZE (56Fe, 1 GeV/n, 150 keV/|j.m) radiation, or sham radiation. The dose of 2.0
Gy was chosen based on my preliminary study where 2.0 Gy significantly inhibited basal
and evoked [3H]-norepinephrine release from rat hippocampal slices (Chapter I,
Preliminary Results). One point four Gy was chosen to approximate doses that inhibit
hippocampus dependent cognitive performance previously reported (9, 10, 36). I have
chosen 0.6 Gy as the lowest test dose, since our behavior data displayed highly variable
performance of 0.6 Gy irradiated animals in hippocampus dependent spatial learning test,
which implies that the dose is capable to induce neurochemical change in hippocampus,
but a degree of change depends on sensitivity to radiation within each individual (45).
As discussed earlier, it is the delayed effects that may lead to severe neurological
consequences in the CNS (46, 47). In this study, animals were sacrificed three and six
months post-irradiation to investigate the early and late delayed radiation effects.
I used synaptosomal preparation to evaluate effects of HZE irradiation on
hippocampal neurotransmission and protein levels. Synaptosomes are isolated nerve
terminals, and have been used as an experimental model system to study the structure and
function of the synapse (48), and synaptic plasticity (49).

8

My findings indicate that a single treatment with 0.6 Gy of 56Fe HZE particlesb
(1 GeV/n, whole-brain irradiation) significantly disturbs functional integrity of the
release machinery of rat hippocampal synaptosomes, and results in the reduction of
evoked [3H]-glutamate and [14C]-GABA release three months post irradiation. A
pronounced change has also been found at the 6 month time-point, indicating that the
effects are persistent. Exposure to 56Fe HZE radiation also significantly perturbs levels of
glutamatergic NMDA receptors and P adrenergic receptors, while levels of marker
proteins for glutamatergic nerve terminals, and glutamatergic synaptic vesicles are not
significantly altered, thus it is unlikely that observed reduction in glutamatergic release is
caused by radiation-induced depletion of glutamatergic store or apoptotic damage of
nerve terminals. Increased level of lipid peroxidation after exposure may be a possible
mechanism of disrupted neurotransmission in the hippocampus.
Considering critical roles of glutamatergic and GABAergic systems, and NMDA
receptors and p adrenergic receptors in learning and memory, my findings provide
experimental evidence which underlie radiation-induced cognitive dysfunction.

INTRODUCTION TO SPACE RADIATION BIOLOGY
Radiation is a process in which energy radiates, i.e. energy travels outward in
straight lines to all directions from a source. When radiated energy hits atoms or
molecules, it may lead to excitation or ionization of them. Excitation is where energy
causes an electron in an atom or molecule move to a higher energy level without actual

'Fe particles are discussed in Chapter I, Introduction to Space Radiation Biology.
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ejection of the electron, while ionization is a process where the incident energy is
sufficient to eject orbital electrons from the atom or molecule. Ejected electrons are
capable of causing damage to biological materials by breaking a chemical bond and
initiating a chain of events, or to induce free radical production. An important
characteristic of potentially hazardous radiation is the ability to ionize, and such radiation
is classified as ionizing radiation.
Ionizing radiation is categorized as either electromagnetic or particulate,
depending on the source of energy. X-rays are a conventional example of electromagnetic
radiation and are used in clinical practice. The source of particulate radiation could be
electrons, protons, a-particles, neutrons and heavy charged ions (HZE, high mass,
highly charged (Z), high energy).
The biological effects of radiation are caused by either direct or indirect action
of ionization. Direct action of radiation is where energy directly interacts with targets in
cells and initiates a chain of events that leads to a biological change (Fig. 1, direct action).
Alternatively, radiation may interact with other atoms or molecules in the cell, for
example, water, to produce reactive oxygen species (ROS) that are able to diffuse to
critical targets and inflict damage (Fig. 1, indirect action). A principal target for direct
action is chromosomal DNA, as depicted in Figure 1.
Galactic cosmic radiation (GCR) is a major constituent of space radiation, which
is composed of protons (85%), helium (14%) and heavier HZE particles (1%) (2).
Although protons make up a large portion of the radiation spectrum, no significant effect
of proton radiation at any dose on behavibral and neurochemical endpoints has been
reported (50). In contrast, HZE particles have multiple biological effects (8, 33, 51, 52).

10

Indirect
Action

FIG. 1. Direct and indirect actions of ionizing radiation. In direct action, an emitted
electron (e") interacts with a target, for example, DNA helix, to produce an insult. In
indirect action, an electron interacts with, for example, a water molecule to produce ROS,
here a hydroxyl radical (OH"), which in turn produces the damage to the DNA. (Modified
from Hall, 2006; ref. 46)
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Thus, the general consensus is that HZE particles represent the most hazardous type of
radiation in space. Human exposure to HZE in space was first described as an episode
during the lunar missions of the 1970's, when astronauts "saw" light flashes with eyes
closed in complete darkness. This phenomenon was caused by HZE particles crossing the
retina. It has been estimated (53) that on a 3-year mission to Mars, 3% of cells in the
body would be traversed by HZE (56Fe) particles even behind aluminum shielding of 4
g/cm 3 00.
HZE particles are nuclei of elements; e.g. carbon, neon, argon, or iron. They are
positively charged because some or all of the planetary electrons have been stripped away
(46). In ground based studies, HZE particles must be accelerated to energies of mega
(106) to giga (109) electron volts, therefore, can be produced in only specialized facilities.
HZE radiation has a characteristic pattern of energy deposition in a defined range along a
linear track. Figure 2 shows computer simulations for track structures of proton (A) and
three types of HZE particles (B, C, D) in liquid water to estimate energy distribution in
biological matter (54). In contrast with a diffuse pattern of proton (A), HZE particle
tracks take the appearance of a dense "bottle brush" pattern with a central "core". In the
core, the local dose may be quite high, but may drop to zero just a few microns away.
Thus, HZE particles are categorized as high LET (linear energy transfer) radiation per
unit length of track.
Another important property of HZE particles is that they undergo nuclear
fragmentation reactions to produce multiple secondary particles (55). These secondary
particles, whose effects are similar to X-rays, create their own tracks (delta-ray) and may
extend the range of effects beyond that of the primary particle. In Figure 2, lateral

12

mm
•'

sm
« •-•-« t-j--i->-».»

B

-«-••-' *

•H l-l'-H'-l-H-H-l^rj^jT^pltnp^p^opf.^,

tO9Q0|

12Q6-

*M

mm
i
fOQOOi

I

i «^l * « > i t i. i t

I- I I ( I I I I

H

\a

1
id

H

* * ' : ' . ' ! » ' . . ' I.' '..' *

i

i

t i » -i i i j

Hif

28§|14*

scoo!
/

>

........ ......1.

* * ^ M » "* f

I-..J-J...I-1.J.J-.-J.

i oxo

#

'-^r-L-.'r*-*-*

•-•-.-I-'-*--»-'

5066

.lano

loom

FIG. 2. Computer simulation of tracks of representative particulate radiation: proton
(A), carbon (B), silicon (C), and iron (D) ion passing through a thin slab (1 um) of liquid
water with initial energy 100 MeV/nucleon. The particles are started in positive Zdirection, and the coordinates are given in Angstrom (A), Lateral tracks indicate delta-ray
from secondary particles. (From Dingfelder, 2006; ref 54)
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delta-ray tracks are shown along the longitudinal primary trajectories.
Also, as the panels B, C, and D show, the greater the nuclear charge (Z), the
higher the ionization density becomes, which leads to the increased probability of a direct
interaction between the particle track and target molecule. A characteristic dense
pronounced track of 56Fe shows that heavy HZE particles could be more devastating.
Another important feature of HZE particles is so called "bystander effect", which
is illustrated in Figure 3 (55). Bystander effect is when an isolated individual cell in a
population is traversed by a particle, both the "hit" cell and many of its "un-hit"
neighbors (bystanders) respond to radiation exposure (56-58). The effect is likely
mediated by damage-inducing factor(s), as transfer of culture medium from an exposed
culture to unexposed cells often exhibits the effect. Protection by ROS (reactive oxygen
species) scavengers such as superoxide dismutase (SOD) or catalase blocks the bystander
effect in some systems, while proteases block the effect in others, thus it is assumed that
damage in a "hit" cell may lead to the spread of either radical products or signaling
proteins to neighboring cells. This effect may persist for several years (58). Although
currently bystander effects have been reported in preparations exposed at low dose, the
existence of the effect provides evidence for damage amplification.
Considering the highly-layered and interconnected structure of the CNS, the
possibility of HZE tracks to cause a "functional micro-lesion" via its characteristic dense
energy deposition pattern or via bystander effect in the organ is extremely high (55), in
contrast to isotropic tissues such as liver Or connective tissue. Thus, the CNS has been
suggested as a system of the body that might be particularly sensitive to HZE particles.

14

Radiation
Transfer of Signals
by Intercellular junctions

**

FIG. 3. "Bystander effect". Damage created in a cell struck by a single charged
particle radiation leads to the spread of signals or toxic products to many neighboring
cells via intercellular junctions, soluble molecules, or remodeling of the extracellular
matrix. The "bystander effect" amplifies the damage from charged particles. •*: DNA
damage. (From Nelson, 2003; ref. 55)
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It is estimated that during a three-year mission to Mars, 2% to 13% of cells in the CNS
would be directly hit at least once by HZE particles (53).
HZE radiation is a heterogeneously composed beam including elements heavier
than helium 4He. On ground level experiments, however, effects of individual ions, such
as 56Fe, are investigated extensively to simulate effects of HZE radiation. 56Fe (Z — 26) is
the most abundant element in the HZE flux, followed by 28Si (Z = 14) (52). 56Fe has the
highest nuclear binding energy derived from the strong nuclear force (Fig. 4). Nuclear
binding energy is defined as energy required for disassembling a nucleus into free
unbound neutrons and protons per nucleon. High binding energy of

56

Fe (8.79

MeV/nucleon) explains an increase in stability toward formation of 56Fe, indicated by the
arrows in Figure 4 (59). Much lighter elements tend to fuse together to yield heavier
elements such as 56Fe, and much heavier elements split apart to yield lighter elements,
also leading to 56Fe production.
Accumulating evidence indicates that 56Fe particles can induce distinctive effect
on biological materials. When behavioral toxicity caused by direct action of HZE on
gastrointestinal system was evaluated using conditioned taste aversion learning, effects of
56

Fe was significantly greater than that of 4He, 20Ne, 40Ar, and even the heavier 93Nb (Fig.

5) (6, 60). One characteristic of 56Fe effects is its extremely steep dose-response curve
(P, di), as observed in Figure 5.

56

Fe also can induce significant effects on motor

performance assessed in wire suspension test (5), and prevent the acquisition of an
amphetamine-induced conditioned taste aversion (8). Since these behaviors depend on
the integrity of the central dopaminergic transmission, it has been suggested that the locus
of

56

Fe induced change is located at the level of the nigrostriatal system (62).
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(From McMurry, 1998; ref. 59)
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FIG. 5. Dose effects of selected HZE particles on conditioned taste aversion (GTA)
production. Rats were presented a novel 10% sucrose solution and immediately exposed
to one of the following HZE particles: 56Fe, iron; 93Nb, niobium; 20Ne, neon; 40Ar, argon;
4
He, helium. The acquisition of a CTA was assessed by subsequent intake of the normally
preferred sucrose solution, and expressed as the percentage of conditioning day sucrose
intake: Higher dose produced a corresponding decrease in all types of particles. Among
these particles, 56Fe particles showed significantly greater behavioral toxicity than other
particles. (From Rabin, 1994; ref. 6)
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Joseph et al. suggested the

56

Fe exposure induced deficits in dopaminergic

neurotransmission are due to decreased sensitivity to muscarinic receptors, which
indirectly contributes to dopamine dependent behaviors. A proposed mechanism
underlining the deficits is radiation induced changes in striatal membrane structure and
fluidity caused by lipid peroxidation, which is known to affect a variety of
neurotransmitter receptor systems (62). Deleterious effects of 56Fe radiation on behavior
were also found in hippocampal dependent learning and memory tests (9, 10, 36). The
hippocampus plays a major role in acquisition of spatial information, temporary storage
of that information, and transfer of information to long term storage to cortical areas (63).
Failure of the hippocampus results in anterograde memory loss that interferes with proper
cognitive functions. The region has been known to be highly vulnerable to insults such as
trauma, ischemia, stress, aging (64), and also radiation. Even extremely low doses (0.005
Gy) of 4 Ar or 56Fe induce a decrease in synaptic density and synaptic spine length in the
mouse hippocampus (65, 66).
In animal behavioral studies, hippocampal integrity is often assayed in spatial
memory tasks. 1.0 Gy to 1.5 Gy of 56Fe radiation caused impairment in spatial memory
performance of rodents tested in Morris water maze (9, 27), Barns maze (67), and 8-arm
radial maze (7 0). These results suggest a detrimental effect of 56Fe particles on
hippocampus dependent cognitive functions, although the underling neurochemical
mechanisms are not fully understood.
Considering these significantly pronounced effects, in this study I choose

Fe

particles to simulate effects of space radiation. 56Fe particles were accelerated to energies
of 1 GeV/n (giga electron volts per nucleon) in the Alternating Gradient Synchrotron in
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Brookhaven National Laboratory of NASA Space Radiation Laboratory (Chapter II,
Materials and Methods in detail), and utilized to irradiate rats.

PRELIMINARY RESULTS
Initially, I had tested effectiveness of

56

Fe particles on catecholaminergic

neurotransmission in several brain regions three month post irradiation. I had used a
slice preparation, which maintains integrity of local neuronal circuits and glial
connection, thus, is suitable to assess neurotransmission ex vivo. I tested transmission of
norepinephrine (NE) and dopamine (DA), which plays important roles in learning and
memory (63), and are vulnerable to radiation (68, 69).
Unlike glutamatergic and GABAergic regulation which rely on dual glialneuronal reuptake property (discussed in Chapter II), catecholamine transmitters are
mostly cleared by transporters on presynaptic terminals. Thus the action of NE or DA is
terminated largely by removal of these by transporters from the synaptic cleft and either
recycled to synaptic vesicles or enzymatically degraded (70). In my experiments,
pargyline, an inhibitor of monoamine oxidase, the major degradative enzyme, was added
to a buffer to prevent conversion of [3H]-DA or -NE to [3H]-metabolites. Thus,
measurement of 3-H indexes [3HJ-catecholamine release, not [3H]-metabolites.
Three brain regions were tested site-by-site: hippocampus, associative cortex
and striatum. Since NE and DA are not uniformly distributed, noradrenergic nerve
terminals in hippocampal slices were labeled with [ H]-NE, while dopaminergic
terminals in striatum and associative cortex were labeled with [3H]-DA. Basal release
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was determined before a depolarization stimulus, 50 mM KC1, was applied to induce
evoked release.
My results demonstrated that exposure to > 2.0 Gy of

56

Fe HZE radiation (1

GeV/n, 150 keV/um) perturbed neurotransmission (Fig. 6), and resulted in significant
reduction in both basal and [K+]-depolarization-evoked

[3H]-NE release

from

hippocampal slices, while [ H]-DA release from cortical and striatal slices was not
significantly altered under the test condition.
Using the same experimental approaches, I have measured release after X-ray
exposure to assess relative biological effectiveness (RBE) of 56Fe radiation. 13 Gy of Xrays produced similar neurochemical changes as observed with > 2.0 Gy of 56Fe radiation.
It reduced both basal and [K+]-depolarization-evoked [3H]-NE release from hippocampal
slices (Fig. 7), while 10 Gy of X-rays did not significantly alter neurotransmitter release
(data not shown). [3H]-DA release from cortical and striatal slices was not significantly
altered under any test conditions (Fig. 7).
In summary, my preliminary results show 1) enhanced radio-sensitivity of the
hippocampus, and 2) high effectiveness of HZE (56Fe) radiation with RBE value 6.5 in
inhibiting hippocampal noradrenergic transmission. The results also serve to estimate
effective

56

Fe radiation doses for our main studies. Determination of RBE to a standard

radiation, or X-rays, is a common practice in radiation research (55, 71). RBE is
calculated as the ratio of the dose of X-rays to the dose of a test radiation that produces
the same biological effect.
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FIG. 6. Over 2 Gy of HZE (56Fe, 1 GeV/n, 150 keV/^m) radiation effects on [3H]catecholaminergic release from rat brain slices: associative cortex (A, B); hippocampus
(C, D); and striatum (E, F). Endogenous norepinephrine (NE) stores in hippocampal
slices were labeled with [3H]-NE. Endogenous dopamine (DA) stores in striatum and
associative cortex slices were labeled with [3H]-DA. Catecholamine release was induced
by depolarization using a 1.5 min pulse of 50 mM KC1 (arrow). Basal and depolarizationevoked release in response to either 2 or 2.25 Gy of 6Fe radiation was determined in
comparison with sham treated animals three month post irradiation. Panel A, C, E:
Representative experiment. Panel B, D, F: Summary data. The fractional release values
under normal conditions were set to 100% and treatment effects were normalized to
control. Data are presented as mean ± SEM (n = 4 rats/treatment). *: P < 0.05, Student's
Mest.
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CHAPTER II
EFFECTS OF HZE RADIATION ON NEUROTRANSMITTER RELEASE

BACKGROUND
In the hippocampus the majority of synaptic activity is driven by the excitatory
neurotransmitter glutamate and I have focused my attention mostly on the glutamatergic
system. Direct involvements of glutamate in learning and memory have been established,
e.g. a critical role of glutamatergic NMDA receptors in long-term potentiation (LTP)
(72), long-term depression (LTD) (73) and memory (74) has been shown.

Disturbance

of the hippocampal glutamatergic neurotransmission also has been implicated in the
pathogenesis of neurological disorders, such as schizophrenia (75), and functional decline
was found during aging (64 for review, 76)
The processes related to the glutamatergic neurotransmission are schematically
depicted in Figure 8. The synthesis of glutamate (GLU) occurs from glutamine (GLN)
through the action of glutaminase (Gln-ase) which is localized in the mitochondria of
glutamatergic nerve terminals (76) (step 1). Glutamate is then incorporated to synaptic
vesicles by vesicular glutamate transporter (VGlut, discussed in Chapter III) (77) (step
2). Glutamate is released from synaptic vesicles into the synaptic cleft upon action
potential triggered by Ca

influx (step 3) and activates lonotropic receptors (AMPA,

NMD A, kainate (KA) (step 4) to produce excitatory postsynaptic potential (EPSP).
Glutamate also activates metabotropic receptors (mGluR), which transduce signals to
enzymatic activity and/or channel activity. The main mechanism for clearing
extracellular glutamate is by uptake through high-affinity neuronal glutamate transporters
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FIG. 8. Schematic representation of glutamatergic neurotransmission; 1) synthesis of
glutamate (GLU) from glutamine (GLN) through the action of glutaminase (Gln-ase). 2)
storing of glutamate into synaptic vesicles. 3) Ca2+ dependent exocitotic release of
glutamate. 4) glutamate activation of its receptors (AMPA, AMPA receptors; KA, kainate
receptors; NMD A, NMD A receptors; mGluR, metabotropic receptors; R-ex,
extrasynaptic receptors (ionotropic or metabotropic)). 5) uptake of glutamate through
high affinity transporters (empty box) located in astrocytes and presynaptic terminals. 6)
synthesis of glutamine from glutamate though the action of glutamine synthetase (Gln-s).
(From Segovia, 2001; ref. 64)
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(excitatory amino acid transporter (EAAT)) located in presynaptic terminal or glial
glutamate transporter (GLT) located in astrocyte surrounding glutamatergic terminals
(step 5). As for the catabolism of glutamate, the glial enzyme glutamine synthetase (Glns) converts glutamate to glutamine (76) (step 7), which is taken up by neurons and is
converted to glutamate.
Glutamate transporters are driven by Na+/K+ electrochemical gradients. The
transport of one molecule of glutamate is coupled to the co-transport of three Na+ and one
H+, and the counter-transport of one K+ (step 5). When these gradients are dissipated and
ionic disequilibrium occurs, glutamate may also be "released" by reverse operation of the
glutamate transporters (step 6). The physiological role of this Ca2+-independent release of
glutamate is questioned, but is associated with excitotoxicity in pathological
circumstances, e.g. ischemia (64).
As Figure 8 shows, synaptic glutamate concentration is the result of a balance
between these neuronal-glial release and uptake processes. This dual-component system
makes it difficult to differentiate between effects on release and re-uptake when brain
slices are used for release experiments/To circumvent this problem, in the present study,
we have utilized isolated nerve terminals, synaptosomes (Fig. 9). Synaptosomes are
prepared by gentle homogenization in iso-osmotic sucrose solution, followed by a series
of differential centrifugations. The purity of synaptosomal preparation is estimated to be
about 70% (78). It contains 1) mitochondria, 2) synaptic vesicles, 3) active zone, a
specialized region of presynaptic plasma membrane where synaptic vesicles fuse, and 4)
attached fragments of postsynaptic membranes containing signal transducing proteins
(Fig. 9) (79). Under proper experimental conditions, synaptosomal preparation is
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FIG. 9. Electron micrograph of rat brain synaptosome. The terminal (T) with
mitochondria (M) is in contact with dendritic spine containing postsynaptic density
(PSD) (small arrow) and a spine apparatus (large arrow). Bar, 300 nm. (From Kiebler,
1999; ref. 80)
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metabolically active. It respires, takes up oxygen and glucose, maintains a normal
membrane potential by extruding Na+ and accumulating K+, and upon depolarization,
releases transmitter in a Ca2+-dependent manner (78). Since glial elements are mostly
eliminated from synaptosomes, glial source of release and uptake is minimized.
In addition to glutamate, I have also investigated GABA and NE release
properties. GABA is the major inhibitory neurotransmitter in the adult hippocampus,
associated with synaptic inhibition by causing a hyperpolarization of postsynaptic
membrane through ionotropic
(70).

GABAB

GABAB

GABAA

receptors, which is coupled to CI" ion conductance

receptors are metabotropic and behavioral studies have suggested that

receptor blockade can improve cognition (41). GABA is synthesized from L-

glutamate by GAD (glutamic acid decarboxylase) which localizes at neurons with the
GABA containing synaptic vesicles. Similar to glutamatergic neurotransmission, GABA
also has dual glial/neuronal reuptake process and after release, the action of GABA is
terminated largely by removal from the synaptic cleft by these transporters.
NE plays a prominent role in hippocampal cognitive function as a neuromodulator.
It enhances LTP, widely believed to be an important cellular mechanism of learning and
memory. Mossy fiber LTP in the hippocampus is modulated by both 0- and a l adrenergic receptors (43, 81, 82). NE has also been known to display vulnerability to
ionizing radiation. After X-ray exposure, NE content in rat brain and heart were reduced
(68) and y radiation reduced NE release in the hippocampus (69). The precise
mechanisms underling these findings are unknown. A pharmacological study implicates
reduced mobilization of intracellular Ca2+ stores (83), however, our own studies
determined only a minor role for internal Ca

stores for neurotransmitter release
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regulation (84). The involvement of hippocampal glutathione's anabolic/metabolic
pathways was also suggested (85).
Synaptic vesicles (SV) cycle between functionally heterogeneous subpopulations
is depicted in Figure 10. After the uptake of neurotransmitters (NT) (step 1), synaptic
vesicles form a cluster termed the reserve pool (step 2). Next, vesicles are docked at the
active zone (step 3), and through an ATP-dependent process, the release machinery is
"primed" (step 4). During priming, fusion core complex, or SNARE complex (soluble Nethylmaleimide-sensitive fusion protein attachment protein receptors), is assembled into
a trans configuration, which contains synaptobrevin (vesicular SNARE motif), SNAP-25
and syntaxin (target SNARE motif on the plasma membrane). This complex spans
synaptic vesicle membrane and plasma membrane, and brings these into close proximity.
Also, synaptotagmin, a putative Ca2+ sensor, constitutively associate with SNARE
complex. Though these processes, synaptic vesicles become fusion competent and form
the readily releasable pool (RRP). After fusion (step 5), synaptic vesicles undergo
endocytosis and recycle via several routes: fast recycling without an endosomal
intermediate (step 6), or clathrin-mediated endocytosis (step 7) with recycling via
endosomes (step 8). The total number of vesicles that participates in exo- and endocytosis
during prolonged stimulation is referred to as the recycling pool. This pool is composed
of the RRP and the reserve pool, which serves to replenish the RRP upon its depletion
(86). Using cultured hippocampal neurons, one study estimated 17 - 20 vesicles in the
reserve pool and 4 - 8 vesicles in RRP, estimating total of 21 - 25 vesicles in the
recycling pool (86).
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FIG. 10. Readily Releasable Pool (RRP) in synaptic vesicle cycle. After synaptic
vesicles are filled with neurotransmitters (NT) (step 1), they form a vesicle cluster that
serves as a reserve pool (step 2). Filled vesicles dock at the active zone (step 3), and there
they undergo an ATP-dependent priming reaction (step 4) which makes them competent
for Ca2+ triggered fusion-pore opening (step 5). Primed synaptic vesicle cluster is termed
RRP. (Modified from Sttdhof, 2004; ref 86)
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RRP informs on synaptic release probability (pr) and synaptic strength (38, 87).
These parameters are actively regulated under physiological conditions, e. g. learning and
memory related processes (88), and under neurodegenerative conditions (89, 90).
I used a pulse of hyperosmotic sucrose to probe the size of the RRP (38, 88). The
30 sec pulse I applied does not induce membrane damage but mimic action potential
evoked vesicular neurotransmitter release (38, 88, 91) with the exception that it does not
require Ca2+ influx. This allowed me to bypass possible treatment effects on Ca2+
homeostasis and focus on HZE radiation induced modulation of the RRP and changes in
the "proximal" release machinery proteins that are directly involved in the synaptic
vesicle cycle.
Whereas action potential/depolarization evoked release is the most studied, even
in the absence of action potentials, synapses exhibit low-probability "spontaneous"
release. This represents mostly fusion of a single synaptic vesicle of a distinct vesicle
pool (92). Spontaneous release had been considered as a "leak" of neurotransmitter in a
random Ca

independent fashion, however, recent studies revealed that spontaneous

release may also be Ca

sensitive, although to a different degree (93). The physiological

role of spontaneous release is not clear, but several roles e.g. spine maintenance, have
been suggested (94). Basal release in my assay may correlate with spontaneous release.
In my release assay, neurotransmitter pools in synaptosomal preparations were
first labeled with 3H or I4C tagged neurotransmitter in a low enough concentration that
would not offset the natural distribution of the endogenous neurotransmitter. In principle,
release of the radiolabel accurately reflects the endogenous neurotransmitter release.
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After I determined basal release, release was evoked by applying a stimulus. Basal and
stimulus evoked neurotransmitter efflux was determined by counting the isotope amounts.

MATERIALS AND METHODS
Animals and Irradiation Procedures
A total of seventy-eight male0 Wistar rats (Harlan Sprague-Dawley, Inc.,
Indianapolis, IN) were used in this study. 49 animals were exposed either to X-rays or
56

Fe radiation, while 29 rats were exposed to the same procedural steps, except that they

received no radiation. These were termed as sham control animals. The animals were 3 to
4 weeks old weighing approximately 180 g when they were received at Eastern Virginia
Medical School (EVMS) or Brookhaven National Laboratory (BNL, Brookhaven, NY)
animal facility. They were allowed to acclimate for at least one week before radiation
exposure.
At about 5 weeks of age, rats were anesthetized with LP. ketamine (80
mg/kg)/xylazine (8 mg/kg) and placed in a custom-made irradiation jig that held their
head in a fixed position by a tooth bar. The jig was placed behind a 6 mm lead shield for

c

Gender differences in response to radiation have been reported in patients receiving cranial radiotherapy

(13, 95). These reports found that girls had increased risk for neurocognitive impairments. However the
underlying mechanisms of gender differences are not well understood. While gender differences to
radiation have important basic science and practical implications at this exploratory stage of the project, I
felt that avoiding the possible influences of menstrual cycle was more prudent. Also, previous HZE
radiation studies mostly used male rodents, allowing more direct comparisons with my studies.
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X-rays or a 40 mm tungsten shield for HZE that protected the anterior portion of the rats'
muzzle and the posterior portion of the body from the pinnae backwards. Body doses of
the cranial dose were 1-3% for X-rays and < 0.8% for HZE. Rats were given a single
dose of irradiation using either X-rays or 56Fe particles. For X-ray exposure, the animals
were given whole brain irradiation of 10 or 13 Gy of 200 kVp X-rays at a dose rate of 3
Gy/min at EVMS. Tron-56 particle radiation (1 GeV/n, LET = 150 keV/um) was
generated using the Alternating Gradient Synchrotron (AGS) in Brookhaven National
Laboratory (BNL) of NASA Space Radiation Laboratory (NSRL). The animals were
given a single dose (0.6, 1.4 or 2.0 Gy) of whole brain irradiation at a dose rate of 0.5
Gy/min. After a week of recovery time, the rats were transported to EVMS.
The animals were housed either singularly or in pairs in standard cages in a group
housing environment, maintained on a 12-h light/dark cycle with lights on from 7:00 AM
to 7:00 PM. Ambient temperature was maintained at 24.5 ± 0.5°C. The rats were given ad
libitum access to autoclaved rat chow and water. Their weight was monitored on a
weekly basis. No specificity of weight loss was observed in any of dose groups.
Three or six months after irradiation, animals were sacrificed under anesthesia of
15% halothane in mineral oil, and brain regions of interest were dissected. These time
points were selected to investigate late-developing radiation effects on the CNS (46),
One half of the brain tissue was immediately used for making slice or synaptosomal
preparations for release assay. The other half was kept as dry tissues at -80°C until use
for western blotting and lipid peroxidation experiments.
The present project was conducted in accordance with the National Institutes of
Health guidelines for the care and use of animals in research, and was approved by the
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Institutional Animal Care and Use Committee of EVMS and by those of BNL. Animal
facilities at EVMS are accredited by the Association for Assessment and Accreditation of
Laboratory Animal Care, International.
Slice and Synaptosomal Preparation
After anesthesia with 15% halothane in mineral oil and decapitation, brains were
rapidly removed and placed into ice-cold phosphate buffered saline (PBS), pH 7.4. The
associative cortex, the hippocampus, and the striatum were dissected using visual
landmarks.
For slice preparation, brain tissues were cut into minces to increase surface area
for radioactive-tagged neurotransmitter uptake and oxygen/glucose supply.
Synaptosomal preparation was made as previously described (88). Briefly, brain
tissues were homogenized at 900 rpm with a motor-driven homogenizer in ice-cold isoosmotic solution containing 0.32 M sucrose, 100 uM EDTA, and 5 mM HEPES, pH 7.4.
Debris and nuclei were pelleted by differential centrifugation at 900 x g at 4°C for 10 min,
and supernatant containing synaptosomes was pelleted at 11,500 x g at 4°C for 20 min.
Final pellets were resuspended in ice-cold aerated (95% O2,5% CO2) Krebs-bicarbonateHEPES buffer (KBH) composed of the following (in mM): NaCl, 118; KC1, 3.5; CaCl2,
1.25; MgS0 4 , 1.2; KH2PO4, 1.2;NaC0 3 ,25; HEPES-NaOH, 5, (pH 7.4); D-glucose, 11.5,
and allowed to equilibrate for at least 30 min on ice. For catecholamine release
measurement, ascorbic acid, 0.6 mM; EDTA (ethylene-diamine-tetra-acetic acid), 0.1
mM; and pargyline, 0.01 mM was added to KBH buffer to reduce chemical oxidization,
free radical formation, and monoamine oxidase (MAO) mediated rapid catecholamine
metabolism.
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Measurement of Radioactive-tagged Neurotransmitter Release from Slices
Neurotransmitter release was measured as described previously (88). To label
endogenous neurotransmitter pool, hippocampal slices were incubated for 30 min with
173 nM [3H]-norepinephrine (NE) (l-[7, 8-3H] norepinephrine, 35.0 Ci/mmol specific
activity, Amersham Biosciences). Frontal associative cortex and striatal slices were
incubated

with

110

nM

[3H]-dopamine

(DA)

(3,

4-[ring-2,

5,

6-3H]-

dihydroxyphenylethylamine hydrochloride, 55 Ci/mmol specific activity, PerkinElmer)
for 30 min at 35°C in freshly bubbled KBH buffer with pargyline addition. Next, slices
were transferred to a superfusion chamber (0.1 ml chamber volume) containing a glass
fiber filter (GF/B) and superfused continuously with bubbled KBH (warmed to 35°C, 0.2
ml/min superfusion rate) for 40 min to remove un-incorporated radioactivity. Three 3min fractions of the superfusate were collected to determine basal level of efflux, then,
evoked release was triggered by rapid switching of superfusion lines from normal KBH
to a KBH containing 50 mM KC1, for 1.5 min to induce neuronal depolarization. In the
depolarizing buffer the NaCl concentration was reduced from 118 mM to 72.7 mM in
order to maintain iso-osmolarity. The total of nine superfusate fractions was collected
continuously throughout the experiment.
Measurement of Radioactive-tagged Neurotransmitter Release from Synaptosomes
To label endogenous neurotransmitter pools, synaptosomes were incubated with
173 nM [3H]-NE (l-[7, 8-3H] norepinephrine, 35.0 Ci/mmol specific activity, Amersham
Biosciences) for 5 min at 35°C in freshly bubbled KBH. To simultaneously measure both
glutamate and GABA release, 115 nM [3H]-glutamate (L-[3, 4-3H]-glutamic acid, 52.0
Ci/mmol specific activity, PerkinElmer, Boston, MA) and 73 nM [14C]-GABA (4-
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aminobutyric acid-earboxy-14C, 8.3 Ci/mmol specific activity, SIGMA) were added to
synaptosomes for 5 min at 35°C in freshly bubbled KBH. Labeled synaptosomes were
transferred to a superfusion chamber (0.1 ml chamber volume) containing a glass fiber
filter (GF/B) covered with 50 ul of 50% Sephadex slurry, and superfused with
continuously bubbled KBH (warmed to 35°C, 0.8 ml/min superfusion rate) for 12 min to
remove un-incorporated radioactivity. Three 1-min fractions of the superfusate were
collected to determine basal neurotransmitter efflux (basal release). Release was induced
by rapid switching of superfusion lines from normal KBH to a KBH containing 0.5 M
sucrose for 30 sec to produce a temporary hyperosmotic shock. The total of nine
superfusate fractions was collected continuously throughout the experiment.
Determining Radioactivity and Calculating Neurotransmitter Release
Tritium and/or 14C contents of individual fractions and activity remaining in the
superfusion chamber was counted at the end of the experiment by liquid scintillation
spectrometer (LS 3801, Beckman Instruments, Inc., Fullerton, CA), which was calibrated
and validated in the range of expected radioactivity efflux values. 14C and 3H decay emit
different energy spectra (18.3 keV, 156 keV, respectively), allowing separate detection.
Release was expressed as the fractional release rate, calculated as the fraction of
radioactivity released at any given time divided by the amount remaining in sample
preparation at that particular time point. Total evoked release was calculated from the
area under the peak.
Statistics
Effects of radiation dose and time course between 3 and 6 month points were
analyzed by Kruskal-Wallis one-way ANOVA on ranks followed by Dunn's method for
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pair-wise comparisons (SigmaStat 2.03). Treatment effects in comparison with controls
were evaluated with Student's i-test or non-parametric Mann-Whitney Rank Sum test
(SigmaStat 2.03) when normality tests failed. Significance was considered at P < 0.05.

RESULTS
Point six Gy of56Fe (1 GeV/n) radiation produced a significant inhibitory effect on [ HJglutamate efflux from the hippocampal synaptosomes
Iron-56 induced CNS effects have several characteristics in common, e.g. either
an extremely steep dose-response curve or the lack of a dose-response relationship
depending on the measured endpoint (61). To evaluate 56Fe radiation dose effect on the
hippocampal nerve terminal, I have tested three doses; 0.6, 1.4, and 2.0 Gy.
Dose-response analysis on 0.5 M sucrose-evoked [3H]-glutamate efflux revealed
that 0.6 Gy of 56Fe radiation (1 GeV/n) produced the most significant inhibitory effect
(14.9 ± 3.61% of control, P = 0.02, Kruskal-Wallis one-way ANOVA followed by
Dunn's pairwise comparison) three months after exposure (filled circle) (Fig. 11), while
1.4 Gy radiation did not significantly alter evoked release (9.6 ± 7.06% of normal). These
results suggest that the threshold for this biochemical endpoint may be equal or lower
than 0.6 Gy three months post irradiation.
Furthermore, six months after exposure (open circle), the inhibitory effect induced
by 0.6 Gy persisted (25.0 ± 5.23% of normal, P = 0.002, Kruskal-Wallis one-way
ANOVA followed by Dunn's pairwise comparison), while the effects of > 1.4 Gy of Fe
radiation were non-significant. Based on these findings, I choose to use a single dose of
0.6 Gy to further investigate biochemical effects of
neurotransmission.

56

Fe radiation on hippocampal
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Figure 12A shows representative experiment on effects of 0.6 Gy of 56Fe radiation
on [3H]-glutamate release from hippocampal synaptosomes. While basal release,
observed the first 4 minute time window, was not significantly affected (95.6 ± 2.08% of
control, Figs. 12B, C), hyperosmotic sucrose evoked [3H]-glutamate efflux from
hippocampal synaptosomes observed 5 and 6 minute time window was

significantly

reduced (85.2 ± 3.61% of control, P = 0.01, Mann-Whitney Rank Sum Test, Figs. 12B,

Effects of 0.6 Gy of56Fe radiation (1 GeV/n) were more pronounced on hippocampal
than associative cortical synaptosomes.
Glutamate is the principal excitatory neurotransmitter in the brain, and is
abundant in the hippocampus as well as in the cortex (70, 96). To determine if the same
dose of

56

Fe particles exerts inhibitory effect on glutamatergic nerve terminals of

different brain regions, I have evaluated [3H]-glutamate release from the associative
cortex. Associative cortex is functionally distinct cortical area, located in the anterior part
of the cortex, which includes prefrontal cortex (PFC). The basic function of the brain area
is to orchestrate goal oriented behavior. Associative cortical glutamatergic system is
vulnerable to aging, and aging induced reduction of glutamate content in the area was
documented(64).
My results showed that 0.6 Gy of 56Fe radiation did not disturb [3H]-glutamate
release in associative cortical nerve terminals when tested three months after exposure
(Fig. 13). Normalized basal and 0.5 M sucrose evoked release were 93.8 ± 4.27% and
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FIG. 12. Effects of 0.6 Gy of 56Fe radiation (1 GeV/n) on [3H]-glutamate release from
rat hippocampal synaptosomes three months post irradiation. (A) Representative
experiment. Glutamate release was evoked from superfused synaptosomes by 30 sec
pulses of hypertonic sucrose (arrow). (B) Summary graph of experiments indicating the
fractional release of [3H]-glutamate basal and hypertonic sucrose evoked release
calculated as the area under the peak. (C) Fractional release values under normal
conditions were set to 100% and treatment effects were normalized to control. Graphs
show means ± SEM (n = 8, each). *': P < 0.05.
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95.5 ±3.05%, respectively. The results suggest that hippocampal glutamatergic nerve
terminals are more sensitive to 0.6 Gy of 56Fe particle radiation.
Point six Gy of56Fe radiation (1 GeV/n) produced a significant inhibitory effect on
hippocampal GABA release
My next question was whether the inhibitory effect of 0.6 Gy of 56Fe radiation
was selective for glutamatergic nerve terminals. To address this question, I labeled
hippocampal synaptosomes with [14C]-GABA as well as [3H]-glutamate to compare both
release in the same preparation. [14C]-GABA is incorporated through nerve terminal and
synaptic vesicle transporters, while [3H]-glutamate is incorporated by a different set of
nerve terminal transporters (GLT-1 and EAAC1) and synaptic vesicle transporter (VGlut).
Release was triggered by a pulse of hypertonic sucrose, and

14

C and 3H contents were

simultaneously collected, as described earlier.
Evoked [14C]-GABA efflux highly correlated with that of [3H]-glutamate (Fig. 14,
R2 = 0.893). 0.6 Gy of 56Fe radiation reduced evoked [14C]-GABA release significantly
(82.5 ± 6.06% of control, P < 0.001, Mann-Whitney Rank Sum Test), while basal evoke
was not altered (97.6 ± 2.62%, n.s., Fig. 15). These data indicate that inhibitory effect of
0.6 Gy of

56

Fe radiation on hippocampal nerve terminals was not selective to the

glutamatergic system, and that the same cellular defects may underlie the functional
impairments in both glutamatergic and GABAergic functions.
Effects of 0.6 Gy of36Fe radiation were not significant on hippocampal noradrenergic
system
I have also tested the effects of 0.6 Gy of

56

Fe particles on noradrenergic

terminals in the hippocampus. Although a trend of decrease was observed in the size of
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(1 GeV/n) was not selective for neurotransmitter types.
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evoked release, it was not statistically significant (91.5 ± 5.20% of control, P = 0.343, Fig.
16). Basal release was spared (107.7 ± 10.65% of control).
The inhibitory effects of 0.6 Gy of 56Fe radiation on [ HJ-glutamate and [ CJ-GABA
release persisted at 6 month post irradiation
To test the temporal changes in HZE induced neurotransmitter release, I have
evaluated the effects of 0.6 Gy of 5^Fe radiation six months after irradiation (Fig. 17). The
results revealed that the effects were persistent on both glutamatergic (evoked release;
75.2 ± 5.23% of control, P < 0.05) and GABAergic release (75.8 ± 3.65 of control, P <
0.005) compared to control. There was a statistically significant difference in time course
effect (glutamatergic, P = 0.002; GABAergic, P < 0.001, Kruskal-Wallis one-way
ANOVA), indicating a possible progressive effect, although measures taken at 3 months
and 6 months were not statistically different. Basal levels of both systems were not
changed: glutamatergic, 103.8 ± 2.33%; GABAergic, 99.6 ± 6.00%. There was no effect
observed in either basal or evoked release from noradrenergic nerve terminals.

DISCUSSION
I found that 0.6 Gy of 56Fe radiation (1 GeV/n) led to significant reduction in
hypertonic sucrose evoked release, a measure of the readily releasable pool (RRP), of two
major neurotransmitters, glutamate and GABA, at three months after exposure. Moreover,
these effects were persistent until six months post radiation.
While further studies with lower doses need to be carried out, 0.6 Gy may be a
threshold dose for inducing impairments in hippocampal glutamatergic and GABAergic
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FIG. 16. Effects of 0.6 Gy of 56Fe radiation (1 GeV/n) on [3H]-norepinephrine (NE)
release from rat hippocampal synaptosomes three months post irradiation. (A)
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neurotransmission. It is of note that the lowest dose we tested induced the largest deficits
in hippocampal neurotransmission. This finding is in line with dose response studies for
the induction of ROS by 56Fe radiation (26). Limoli and co-authors found that in a range
of low dose (0.25 ~'l Gy) of 56Fe particles, ROS production was linear until a peak was
reached at 1 Gy. After that point, ROS production started to decline. Rabin and coworkers also documented that the dose-response curve of 56Fe particle induced changes in
neurochemical function are extremely steep (61). They observed a significant reduction
in K+-depolarization evoked striatal DA release by doses 0.1 to 0.5 Gy, but there was no
effect when dose was increased to 5 Gy.

Thus, my results are consistent with the

characteristics of 56Fe irradiation reported by others.
In contrast to glutamatergic and GABAergic impairments, release from the
noradrenergic nerve terminals was not significantly changed by the same regimen of
irradiation. It is noteworthy that 2.0 Gy of 56Fe particle could induce significant reduction
in depolarization evoked [3H]-norepinephrine release from slices of rat hippocampus
(Chapter I, Preliminary Results), suggesting that threshold dose to cause perturbation in
hippocampal noradrenergic neurotransmission may be higher than 0.6 Gy. Alternatively,
it is possible that other elements of neurons, not terminals, which are preserved in slices,
but not in synaptosomes, may be direct targets of radiation.
Glutamate and GABA are the two major neurotransmitters in the hippocampus
and are involved in cognitive functions. The hippocampus is vulnerable to aging, and
numerous studies suggest that disintegrating glutamatergic neurotransmission is a factor
in aging (64, 97, 98). It is noteworthy that radiation accelerates aging, and the similarity
of aged rats and

56

Fe irradiated rats in measures of nigrostriatal system dependent
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functions (5) and in hippocampal dependent spatial learning and memory (9) have been
noted.
My results also indicate that the effect of 0.6 Gy of

56

Fe radiation is region

specific; glutamatergic chemical transmission was disturbed in nerve terminals of the
hippocampus, while it was normal in the associative cortex. The nature of this region
specificity is difficult to discern at the present level of investigation. One possible
explanation may be regional differences in antioxidative activities. Todorovic et al. found
that after 2.0 Gy of y-radiation exposure mitochondrial superoxide dismutase (SOD)
activity was significantly lower in the hippocampus than in the cortex (37). Considering
that mitochondrial SOD is induced in response to radiation, and that neurons cannot
tolerate the depletion of mitochondrial SOD, their finding, at least partially, may explain
the higher radio- vulnerability of the hippocampus.
Despite significant reduction in evoked release in glutamatergic and GABAergic
nerve terminals, basal release remained unchanged in both nerve terminals. Basal release
reflects spontaneous release, which is independent of action potential depolarization.
Studies have shown that spontaneous release may originate from a different vesicle pool
from the RRP with different states of releasability (92). The exact nature of the molecular
diversity between these two vesicle pools remains to be identified, although it has been
suggested that isoforms of SNARE proteins involved in basal release are different from
those participated in evoked (92, 93). My findings of unaltered basal release and
significantly altered evoked release, thus, suggest that radiation effects may have spared
proteins underlining spontaneous release, and also the basic release machinery.
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The question still remains, however, as to the locus of the radiation-induced
deficit(s) in perturbation of glutamatergic and GABAergic release. The extent of
hypertonic sucrose evoked release probes the size of the RRP, which reflects the rate of
recycling of synaptic vesicles during extended stimulation (99). Upon depletion of
vesicles in RRP, vesicles are replenished from a reserve pool. Reduction in release might
reflect radiation induced change in size of the reserve pool, or total size of the recycling
pool, which combines both RRP and the reserve pool. To test this, I have investigated
effects of 56Fe radiation on the abundance of synaptic vesicles by quantitative analysis of
synaptic vesicle marker proteins (Chapter III).
Moreover, significant influence on the size of release originates Ca dynamics,
which depends on: 1) numbers and types of voltage-gated Ca2+channels.; 2) Ca +
buffering and transient local Ca2+ concentration; and 3) Ca2+-binding property of Ca2+
sensor (86, 99). These factors will influence the size of hyperosmotic sucrose evoked
release, even though the stimulus itself does not require influx of Ca2+. Thus, any change
that alters composition and tension of the participating membranes of the active zone
influences neurotransmitter release, even by simply stretching the membrane (100).
Considering oxidative effects induced by radiation and increased levels of lipid
peroxidation previously documented (27, 36), there may be possible alterations in
membrane structure and fluidity after 0.6 Gy

56

Fe irradiation. Consequence of lipid

peroxidation is unregulated membrane potential (101), which may imbalance cytoplasmic
Ca2+ concentration and ultimately affects Ca2+ dependent steps of the synaptic vesicle
cycle. I have tested the level of lipid peroxidation in the hippocampus, and obtained
supportive results (Chapter IV).
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CHAPTER III
EFFECTS OF HZE RADIATION ON
SELECTED SYNAPTIC PROTEIN LEVELS

BACKGROUND
In the previous chapter I reported significant reduction of hypertonic sucrose
evoked release from glutamatergic and GABAergic nerve terminals in the hippocampus,
three and six months after exposure to 0.6 Gy of 56Fe radiation. The reduction could be a
reflection of radiation induced depletion of synaptic vesicle pools. To address this, I
assayed synaptic vesicle marker protein levels in hippocampal synaptosomes after

56

Fe

irradiation. Synaptophysin was used as a general marker of all synaptic vesicle types and
VGlutl (vesicular glutamatergic transporter 1) was used as a marker of glutamatergic
synaptic vesicles.
Neurotransmitter receptor levels are differentially regulated during development
(102), and in synaptic plasticity processes (103). Membrane structure and fluidity (62)
and radiation (25) also affect neurotransmitter receptor levels. Because of the importance
of those proteins in glutamatergic, GABAergic and noradrenergic transmission, I
determined levels of glutamatergic AMPA (a-amino-3-hydroxy-5 -methyl -4-isoxazolepropionic acid) and NMDA (N-methyl D-aspartate) receptors (NR1, NR2A and NR2B),
GABAergic (y-amino butyric acid)

GABAA

and

GABAB

receptors, and noradrenergic al,

a2 and pi adrenergic receptors after 0.6 Gy of 56Fe radiation exposure.
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PSD-95 (postsynaptic density 95 kDa), a scaffold protein which anchors
glutamatergic receptors, was also tested to evaluate whether number or size of excitatory
postsynaptic contacts were affected.
To probe a possible neuronal regeneration as compensatory response after
irradiation, I also have analyzed the level of MAP2 (microtubule associated protein 2),
which is involved in the stabilization and extension of dendrites (104).
Each protein is discussed in the following sections.
Synaptophysin
Synaptophysin is a synaptic vesicle associated protein that constitutes about 7%
of the total vesicle proteins (105). Due to its ubiquity at all types of synaptic vesicles, it
has been widely used as a general marker for nerve terminals (106, 107). Synaptophysin
interacts with an essential SNARE protein (soluble N-ethylmaleimide-sensitive factor
attachment protein receptor), synaptobrevin (also referred to as VAMP, vesicle associated
membrane protein). Exact function of the synaptophysin-synaptobrevin complex is
largely unknown, however it is speculated that synaptophysin may temporally restrict
availability of synaptobrevin by binding to it (106).
Since synaptophysin levels positively correlate with the number of synaptic
vesicles (68), I have used this protein as a general marker of total synaptic vesicle pool in
nerve terminals.
VGlutl
VGlutl is a transporter of glutamate into synaptic vesicles. VGlutl is driven by an
ATP dependent electrochemical proton gradient. Since VGlut is exclusive to vesicles
containing glutamate, and undetectable in other neuron types or neuronal components
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(77), it has been used as a marker for glutamatergic synaptic vesicles and nerve terminals.
Two isoforms, VGlutl and VGlut2, are identified in glutamatergic synapses. Both mRNA
(75) and protein (108) levels of VGlutl are predominant in hippocampus, thus, VGlutl is
more extensively used for hippocampal studies (108).
A recent study showed diminished VGlutl expression in the hippocampus and
prefrontal cortex of schizophrenic patients, suggesting usefulness of this marker in
pathological studies (75). Glutamate is a ubiquitous amino acid in neural tissue and
participates in a variety of intermediary metabolisms. For example, glutamate functions
in the detoxification of ammonia, is a building block in the synthesis of proteins and
peptides including glutathione, and is a precursor in GABA synthesis. Only 20 to 30% of
neural glutamate content functions as an excitatory neurotransmitter.
To evaluate 56Fe radiation effects on glutamate as a neurotransmitter, I assayed
VGlutl levels, as a measure of total glutamatergic synaptic vesicle pool.
Glutamatergic receptors
A recent study showed that rats subjected to a clinically relevant regimen of
radiation induced significant reduction in performance of hippocampus dependent
learning tasks, and also that the same regimen altered NMD A receptor levels in the
hippocampus, indicating a role of NMDA receptors in radiation induced cognitive
impairments (25). The importance of glutamatergic NMDA receptors in LTP (40) and
LTD (73) has been well documented, providing a strong link between the glutamatergic
systems and the mechanisms of learning and memory (40, 74). These results prompted us
to evaluate NMDA receptor levels after 56Fe irradiation.
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The NMDA receptor functions as a glutamate gated ion channels that is highly
permeable to Na+ and Ca2+. Mg2+ blocks this NMDA channels in a voltage-dependent
manner, thus, rendering NMDA receptors voltage sensitive. NMDA receptors are
heterometric complexes consisting of obligatory NR1 and various NR2 subunits. The
NR1 subunit serves as a key subunit essential for ion selectivity of the NMDA channels,
whereas the NR2 subunit mainly participates in channel gating by voltage and Mg . Liu
and co-authors reported that distinct NMDA subunits were critical factors to determine
the direction of synaptic plasticity (73). They found that the activation of NR2Acontaining NMDA receptors led to LTP formation, while the activation of NR2Bcontaining NMDA receptor produced LTD (73). Although this is still under debate, e.g.
other group demonstrated NR2B's involvement in LTP (109), general consensus is that
the combinations of NR1 with different NR2 subunits give rise to functional diversity.
To probe the effects of HZE radiation on these functionally different subunits, I
have used antibodies against NR1, NR2A and NR2B subunits.
In addition, I have extended our investigationto AMP A receptors, another type of
glutamatergic ionotropic receptors, which possess mostly Naf-permeable channels.
Excessive release of glutamate may cause overload of cellular Na+ and Ca2+ through
these glutamatergic ionotropic receptors, leading to excitotoxic cell death. Such scenario
may play a role in cerebral ischemia and traumatic brain injury, and also, in chronic
neurodegenerative disorders, such as amyotrophic lateral sclerosis (ALS) (110),
Parkinson's disease (111) and Alzheimer's disease (112).
AMPA receptors respond faster to glutamate than NMDA receptors and mediate
the bulk of rapid excitatory synaptic current induced by glutamate (113). Previous results
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showed that LTP requires insertion of new AMP A receptors to the synapse by a
mechanism that involves the association between GluRl AMPA subunit and a PDZ
domain protein, such as PSD-95 (discussed below) {114).
To probe the effects of HZE radiation on levels of AMPA receptors, I have used
antibody against GluRl subunit.
GABAergic receptors
GAB A is the major inhibitory neurotransmitter in the adult hippocampus and
can hyperpolarize postsynaptic membrane by influx of CI" through
Metabotropic

GABAB

GABAA

receptors.

receptors are coupled to cAMP, K+ channel or Ca2+ channel

regulation. Behavioral studies have suggested that

GABAB

receptor blockade can

improve cognition (41).
To probe the effects of HZE radiation on levels of GAB A receptors, I have used
antibody against

GABAA

and G A B A B subunits.

Noradrenergic receptors
NE is a neuromodulator and plays a prominent role in learning tasks (44). It
transmits the effects through three subtypes of receptors; i.e. Gq-coupled al-, Gi-coupled
a2-, and Gs-coupled pi-adrenergic receptors. NE activates cAMP-dependent PKA and
calmodulin-dependent protein kinase (CaMKII) via (31 adrenergic receptors, and
stimulation of pi adrenergic receptors leads to profound effects on the induction of LTP
in multiple hippocampal pathways (42, 43, 115). NE also modulates LTP through al
adrenergic receptors (43, 81, 82), and reduces LTP through Gi-coupled <x2 adrenergic
receptors (116). Since NE is released during emotional arousal, its involvement in
emotional influence on learning and memory has been suggested. Supporting this notion,
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recent study showed that NE-driven phosphrylation of GluRl subunit of-AMPA receptors
facilitates synaptic delivery of AMP A receptors in LTP expression (117).
To test for possible radiation effects on noradrenergic signal transmission, I have
used antibodies against al-, a2- and (31-adrenergic receptors in this study.
PSD-95
The postsynaptic compartment of excitatory synapses is characterized by an
electron-dense region, referred to as the postsynaptic density (PSD) (indicated by small
arrows in Figure 9) that consists of adhesion molecules, neurotransmitter receptors, and
high density of scaffolding proteins. PSD-95 (PSD-95 kDa) is a major scaffold protein
enriched at glutamatergic postsynaptic membranes. By homomultimerizing through Nterminus, PSD-95 molecules form a scaffold. PSD-95 contains three PDZ domains (a
domain commonly discovered in PSD-95/Dlg/ZOl proteins), which anchor various
proteins such as adhesion molecules, e.g. neuroligin-1, glutamatergic NMDA receptors,
and through an adapter protein, stagazin, glutamatergic AMP A receptors. PSD-95
controls subcellular localization of glutamatergic receptors by facilitating alignment of
postsynaptic receptors with the presynaptic active zone.
The reduced glutamatergic release we observed (Chapter II) may produce a
coordinated reduction in the levels of PSD-95. To test this possibility, I have determined
PSD-95 levels by immunoblotting.
MAP2
Microtubules are major structural components of the neuronal cytoskeleton in
axons and dendrites. MAPs (microtubule-associated protein) are a family of proteins
involved in neuromorphogenesis, among which MAP2 is the best characterized. In
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mature neurons MAP2 is compartmentalized within dendrites of neurons {118) and
largely excluded from axons (119). It forms microtubule bundles with straight and rigid
appearance (120). MAP2 also plays an important role in the extension of the dendritic
cytoskeleton and in dendritic stability by forming cross-bridge between microtubules and
other cytoskeletal elements (104). Multiple lines of evidence also indicate that MAP2
levels correlate with neuronal response to oxidative stress (121, 122). Treatments with
H2O2 led to a remarkable reduction in MAP2 levels, while antioxidant treatments upregulated MAP2 levels.
The MAP2 family consists of three isoforms, MAP2a, 2b and 2c. Each has 3 to 4
microtubule-binding repeats near the C-terminus (123) and an N-terminal projection
domain of varying size, which has a net negative charge and exerts a long-range repulsive
force (124) that regulates microtubule spacing (118). MAP2a and 2b are large proteins
with longer projection domains (Mw 280 kDa), while MAP2c, which is often highly
expressed during early development, is smaller (Mw 70 kDa). Different MAP2 isoforms
may have distinct capacities in stabilizing the cytoskeleton. And MAP2c may have the
highest capacity to interact with both microtubules and F-actin (125). It induces neurite
initiation by reorganizing a primary actin-rich structure into a secondary microtubule-rich
structure (122).
MAP2c may have at least two phosphorylated sites, and is a substrate for a
number of protein kinases (126). It has been suggested that MAP2 phosphorylation state
may modify microtubule stability, and thus, regulate neuronal development (126, 127).
Previous studies found that highly phosphorylated MAP2c showed a lower affinity for
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microtubule, resulting in decreases in microtubule bundling (126), although precise
functions of individual phosphorylation sites are not known.
I measured MAP2c levels as an index of dendritic neuronal response to radiation
induced oxidative stress.

MATERIALS AND METHODS
Sample Preparation for Western Blotting
Samples were prepared from hippocampal tissues as described earlier (Chapter II,
Materials and Methods, Sample Preparation). After thawing frozen samples on ice,
tissues from 4 to 6 animals were pooled. This was necessary for obtaining reliable signals
in the dynamic range of detection from low density synaptic proteins. Pooled tissues were
homogenized in isotonic sucrose containing 0.32 M sucrose, 100 uM EDTA, and 5 mM
HEPES, pH 7.4, and synaptosomes were prepared. Total protein concentration in SI
fractions was determined using the Coomassie Plus better Bradford assay kit (Pierce)
according to manufacturer's instructions.
Simultaneous Detection of Two Proteins on Western Blots using Two Near-Infrared (IR)
Fluorophores
Synaptosomes were suspended in SDS-PAGE sample buffer with 8 M urea and
2% mercaptoethanol, and incubated at 60°C for 20 min to accelerate protein denaturing.
Proteins were separated on 3% polyacrylamide stacking and 7.5% running gels for 20
min at 80 V followed by 40 min at 150 V, then transfer to nitrocellulose membrane
(Whatman, Dassel, Germany) for 1 h at 1.5 A in a high intensity field kept at room
temperature by a cooling coil (Bio-Rad, Hercules, CA). Membranes were blocked in
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buffer containing 5% nonfat milk and 5% porcine serum in TBST (Tris-buffered saline
Tween-20) containing Tris 20 mM, NaCl 134 mM, pH 7.6 with 0.1% v/v Tween-20 for
30 min at room temperature, and then incubated with primary antibodies overnight at 4°C.
I utilized Odyssey (Li-Cor) Multiplexed Detection which uses two IR
fluorescence channels for simultaneous analysis of two targets. Two primary antibodies
from different host species were incubated together to probe a blot; rabbit antibody
against a protein of interest, and mouse antibody against loading controls, actin or vasolin
containing protein (VCP). After washing with PBS (phosphate buffered saline)
containing 0.01 M phosphate buffer, 2.7 mM KC1, and 137 mM NaCl, pH 7.4 with 1%
Tween-20, incubation with two IR-conjugated secondary antibodies was carried out for 1
hour at room temperature. Five washes were carried out to remove nonspecific antibody
binding in PBS with 1% Tween-20, or plain PBS.
Visualization of the Western blot signals from two IR fluorophores was done
using the Odyssey IR Imaging System (LICOR, Lincoln, NE) in 700 and 800 nm
channels in a single scan at 42 urn high resolution. Quantification was performed with
Odyssey Application Software version 2.1 (LICOR, Lincoln, NE).
Integrated intensity signal was normalized for loading controls to gain a measure
independent of sample loading errors. For each specific protein, I optimized general
immunoblotting parameters (Table 2) and determined the linear range of IR fluorescence
signal, by loading different protein amounts of the sample.
In some cases where the two primary antibodies were raised in the same species,
diluent dilutions factor of secondary antibody were determined to obtain conditions with
the least competition between the primary antibodies for the secondary antibody. Samples

rabbit polyclonal human aa. 166-296
mouse monoclonal Rat R2 aa. 809-930

25 ug
25 ug

80 ug
80 ug
80ug

20ug

<10ug

GABAAal
GABAB

al
a2A
(il

Synaptophysin

VGlutl

PSD-95

MAP2

1:500

mouse monoclonal Rat aa. 353-504
rabbit polyclonal Mouse aa. 2-309

25 ug

25 ug

1:1000

1:10000

1:25000

1:250
1:250
1:250

1:250
1:250

1:500
1:500
1:250
1:500

rabbit polyclonal Rat aa. 456-560

mouse monoclonal Rat aa. 205-306

rabbit polyclonal human aa. 339-349
rabbit polyclonal KASRWRGRGMEKR
rabbit polyclonal Mouse aa. 394-408

rabbit polyclonal C-terminaloiratMtl
rabbit polyclonal Mouse aa. 1265-1464
rabbit polyclonal
rabbit polyclonal Rat aa. 276-287

25 ug
25 ug
40 ug
25 ug

NMDAMU
NMDAM12A
NMDA!<*R2B
AMPAGluRl

Protein loaded la:

1:15000

1:15000

1:15000

1:15000

1:15000
1:15000
1:15000

1:15000
1:15000

1:15000
1:15000
1:10000
1:15000

actin 1:5000 IRDye 6801:15000

adin 1:5000 IRDye 6801:15000

actin 1:5000 IRDye 6801:15000

VCP 1:250 IRDve680 1:15000

actin 1:5000 MDje 6801:15000
VCP 1:250 IRDje6801:15000
actin 1:5000 IRDye 6801:15000

VCP 1:250 IRDye6801:15000
actin 1:5000 IRDye 6801:15000

adin 1:5000 IRDye 6801:15000
adin 1:5000 IRDye 6801:15000
actin 1:5000 IRDye 6801:15000
actin 1:5000 IRDye 6801:15000

Loading Control
1" Ab. Dilution, 2uAb. Dilation

IRDye 680 conjugated goat (polyclonal) anti-mouse IgG
IRDye 800 conjugated goat (polyclonal) anti-rabbit IgG
actin: mouse monoclonal
VCP: mouse monoclonal

IRDyeSOO

IRDye 680

IRDyeSOO

IRDye 680

IRDye800
IRDyeSOO
IRDyeSOO

IRDye 800
IRDye 680

IRDyeSOO
IRDyeSOO
IRDyeSOO
IRDyeSOO

Optimized General Immunoblotting Parameters
Secondary Ab
Primary Ab
Produced in
Immunogen
Dilation
Dilation

TABLE 2
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were assayed in duplicates for each experiment, and each experiment was repeated at
least three times.
Antibodies
The rabbit polyclonal antibodies against; NR2A, TSTR1 and GluRl were purchased
from Millipore (Temecula, CA), NR2B, al,and pi were from Abeam (Cambridge, MA),
GABAA was from BD Biosciences (San Jose, CA), a2 was from Neuromics (Edina, MN),
and VGlutl and MAP2 were from Synaptic Systems (Goettingen, Germany), The mouse
monoclonal antibodies against synaptophysin, actin, PSD-95,

GABAB

and VCP were

purchased from BD Biosciences (San Jose, CA). Goat anti-rabbit or goat anti-mouse
antibodies conjugated to IR dyes (IRDye 800CW, IRDye 680, respectively, were
purchased from LI-COR, Lincoln, NE).
Statistics
The results were analyzed by Student's Mest to evaluate treatment effects in
comparison with sham-control. Time course effects were evaluated by Kruskal-Wallis
one-way ANOVA followed by Dunn's pairwise comparison to assess three and six
months post radiation effects. Differences between means were considered significant at
P<0.05.

RESULTS
Reduction of [ HJ-glutamate release was not due to decrease in nerve terminal number
or in glutamatergic synaptic vesicle number.
My findings on 0.6 Gy of 56Fe radiation induced reduction in RRP (Chapter II
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Background in detail) raised the possibility of nerve terminal loss or reduced
glutamatergic synaptic vesicle numbers. I have assessed the levels of VGlutl and
synaptophysin in hippocampal synaptosomes obtained from rats subjected to

Fe

irradiation to investigate synaptic vesicle densities on nerve terminal,
VGlutl antibody detected a single band at approximately 70 kDa (Fig. 18B). The
synaptophysin antibody also detected a single band migrating at approximately 40 kDa
(Fig. 18B). These immunoreactive bands corresponds to the previously published
molecular weights of VGlutl (70-80 kDa) and synaptophysin (38 kDa) (106, 108).
Normalized levels of integrated intensity showed that

56

Fe radiation did not have a

significant effect on VGlutl or synaptophysin immunoreactivity (Fig 18A, Table 3) three
and six months post irradiation. These results suggest that radiation did not cause global
changes in glutamatergic nerve terminal population, or in glutamatergic synaptic vesicle
numbers.
0.6 Gy of56Fe radiation significantly reduced levels ofNMDA, but not AMP A receptors .
3 months post irradiation
It was previously reported that ionizing radiation affected glutamatergic NMDA
receptor levels (25). I assessed NMDA and AMPA receptor abundance in hippocampal
synaptosomes obtained from rats subjected to 0.6 Gy of

56

Fe irradiation. The NR1

antibody detected a strong band at 120 kDa, and the NR2A antibody detected a strong
band at 170 kDa (Fig. 19B). The NR2B antibody detected two bands at approximately
180 kDa and 150 kDa. The lower band was probably a product of proteolytic degradation
(128). Our results showed that degradation rate calculated as intensities of 150 kDa over
180 kDa was not significantly altered after irradiation.

62

3 Months
6 Months
VGIutl

ixe

•| g

0)
N 0_
re • o

F
L.

<-•

«J

Syn

0)

B
kDa

3 Months

0

70-80
4238-

6 Months

0.6

0

•

0.6
i

(C5y)
k

•

*.-

VGIutl
actin

^^l^^^^^^gy^^l^.

ttHBI

Syn

- . f f . i j K s J ^ J w •-"-''•":•

97-

~_ .

_-

^

VCP

FIG. 18. Effects of 0.6 Gy of 56Fe radiation (1 GeV/n) on VGIutl and synaptophysin
levels. Protein levels were analyzed by quantitative western blotting, using VGIutl and
synaptophysin antibodies. Data were normalized to sham irradiated values, which was set
to 1. Data shown are means ± SEMs. (A) Summary graph of VGIutl and synaptophysin
(Syn) levels in hippocampal synaptosomes three and six months post irradiation. (B)
Representative immunoblots of VGIutl and synaptophysin (Syn) with loading controls,
actin and VCP, respectively.
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TABLES

Proteins

Change of Levels ini Selected Synaptic Proteins
3 and 6 Months Post 0.6 Gv ^Ee Irradiation
3 Months
6Months
Integrated intensity p value Integrated intensity

p value

NMDA NR1
NMDANR2A
NMDANR2B
AMPA GluRl

0.894 ±0.023
0.792±0.023
0.783 ±0.073
1.038 ±0.063

.•D.01.0
*0.001
*0.024
0.583

1282 ±0.055
0.905 ±0.035
0.933 ± 0.073
0.913 ±0.126

*0.007
*0.033
0.396
0.528

GABA A al
GABAB

0.972 ±0.100
0.904 ± 0.161

0.672
0.584

1.003 ±0.154
0.963 ± 0.123

0.984
0.712

al
a2A

PI

0.876 ±0.117
0.917 ±0.175
0.612 ±0.156

0260
0.607
*0.038

0.954 ±0.108
1.120 ±0.072
0.998 ± 0.045

0.692
0.172
0.959

Synaptophysin

1.076 ±0.031

0.069

1.046 ±0.032

0.220

VGutl

1.172 ±0.114

0.183

1.093 ±0.136

0.531

PSD-95

0.899 ±0.047

0.097

0.907 ±0.136

0.519

MAP2c

0.861 ±0.047

*0.018

1238 ±0.044

*0.006

: P < 0.05, analyzed by Student's t -test (two-tailed distribution)
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FIG. 19. Effects of 0.6 Gy of 56Fe radiation (1 GeV/n) on selected glutamatergic
receptor levels. Protein levels were analyzed by quantitative western blotting. Data were
normalized to sham irradiated values, which was set to 1. Data shown are means ± SEMs.
(A) Summary graph of NMDA NR1, 2A, 2B and AMPA GluRl levels in hippocampal
synaptosomes three and six months post irradiation. (B) Representative immunoblots. *:
P < 0.05 analyzed by Student's Mest compared to control.
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The 150 kDa unit is a constituent of the NMD A receptor complex. It is stable and
maintains basic properties, suggesting functionality (128). Thus, I added up intensities
from both bands to quantify NR2B levels. A representative band at 180 kDa is shown in
Figure 19B. The AMPA antibody detected a strong band at 100 kDa.
For all three NMD A receptor subunits, normalized integrated intensity was
significantly

reduced

three

months

post

irradiation,

while

AMPA

receptor

immunoreactivity was spared (Fig 19A, Table 3). The effects were statistically significant,
and were more pronounced on NR2 subunits. Both NR2A and NR2B isoform levels were
reduced by « 20% (NR2A: 0.79 ±0.02 of control: NR2B, 0.78 ± 0.07 of control).
Six months post irradiation, however, the levels returned to normal. The levels of
NR2 subunits were comparable to controls, whereas NR1 levels were up-regulated by
28%. Statistical analysis revealed a significant time course effect on NR1 receptors
between three and six months (Kruskal-Wallis one-way ANOVA on ranks followed by
Dunn's pairwise comparison, P = 0.004). AMPA levels were unaltered six months post
irradiation.
Radiation exposure did not change PSD-95 levels
Either directly or indirectly, reduction in glutamatergic release and level of
NMD A receptors might produce a coordinated change in a major glutamatergic receptor
scaffolding protein, PSD-95. The PSD-95 antibody I used detected a single band at
approximately 95 kDa, as expected (Fig. 20B). Three months after exposure the level of
PSD-95 showed a trend of decrease (0.90 ± 0.05 of controls), but this was not statistically
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FIG. 20. Effects of 0.6 Gy of 56Fe radiation (1 GeV/n) on PSD-95 levels. Protein
levels were analyzed by quantitative western blotting, using PSD-95 antibodies. Data
were normalized to sham irradiated values, which was set to 1. Data shown are means ±
SEMs. (A) Summary graph of PSD-95 levels in hippocampal synaptosomes three and six
months post irradiation. (B) Representative imniunoblots.
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significant (Fig. 20A, Table 3). The level was unchanged when tested six months after
irradiation (0.91 ±0.14 of controls).
pi adrenergic receptor displayed significant radio-sensitivity 3 months post irradiation,
whereas GABA and a-adrenergic receptors did not.
In addition to glutamatergic receptors, I have evaluated levels of GABAergic and
noradrenergic receptors. I found both
resistant to 0.6 Gy of

GABAA

and

GABAB

receptors were relatively

56

Fe irradiation. The levels of these receptors did not show any

significant changes in comparison with control at either 3 or 6 month time point (Table 3).
Among three noradrenergic receptors tested, only the level of pi adrenergic receptor was
significantly reduced three months after irradiation (Fig. 21, Table 3), while a subunits of
adrenergic receptors were not altered (Table 3). p receptor levels returned to normal six
months post irradiation (Table 3).
Radiation induced a reduction in MAP2c levels 3 months post irradiation that recovered
6 months post irradiation
To assess the possibility of neurite degeneration/regeneration, I tested MAP2
levels in hippocampal synaptosomes. The MAP2 antibody detected two strong bands for
MAP2 isoforms at approximately 280 kDa (MAP2a and 2b), and 70 kDa (MAP2c), as
previously documented {129). Thirty percent of total signal came from MAP2c alone
(30.9 ± 3.92% in sham-control). The results verified that MAP2c, which is highly
expressed during early neuronal development (118), was still detectable in the 4 - 7
months old test subjects. Although MAP2a/2b levels did not significantly change,
MAP2c levels showed significant changes both at three and six months post irradiation.
Western blots identified three major MAP2c species with slightly different
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FIG. 21. Effects of 0.6 Gy of 56Fe radiation (1 GeV/n) on |31 adrenergic receptor
levels. Protein levels were analyzed by quantitative western blotting. Data were
normalized to sham irradiated values, which was set to 1. Data shown are means ± SEMs.
(A) Summary graph of J31 adrenergic receptor levels in hippocampal synaptosomes three
and six months post irradiation. (B) Representative immunoblots. *: P < 0.05 analyzed by
Student's Mest compared to control.
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electrophoretic mobility, which may be due to different phosphorylation states (126) (Fig.
22B). The highest electrophoretic mobility MAP2c species (band 1), which showed the
strongest immunoreactivity, is likely to be in de-phosphorylated state. Levels of band 1
showed 14% reduction three months after exposure (Fig 22A, P = 0.02, Student's /-test).
More interestingly, at six months post-irradiation, intensity of this MAP2c species were
up-regulated by 24% in comparison with sham-control (Fig 22A, P = 0.01). The
difference in the mean values between these two time points was statistically significant
(one-way ANOVA;P< 0.001).
As thephosphorylated states of MAP2c species, i.e. band 2 /band 1 and band 3 /
band 1 ratios, were unaltered at three months post irradiation, no radiation effects on
phosphorylation were suggested. However, at six months post irradiation, band 3 / band 1
ratio was significantly reduced compared to control by 20%, indicating reduced
phosphorylation state of MAP2c. Since MAP2c species in de-phosphorylated state are
more likely to regulate microtubule growth and stability (126), the band 1 level results,
i.e. reduction at 3 months and up-regulation at 6 months post irradiation, suggest
dendritic degeneration and dendritic growth, respectively, which may correspond with
our findings on NMDA and pi receptor levels.

DISCUSSION
The most significant finding in this study was the inhibitory effects of 0.6 Gy of
56

Fe radiation on the levels of glutamatergic NMDA receptors and pi adrenergic

receptors. For all three NMDA receptor subunits tested, namely NR1, NR2A and NR2B,
levels were significantly reduced three months post irradiation. Inhibition or reduction of
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FIG. 22. Effects of 0.6 Gy of 56Fe radiation (1 GeV/n) on MAP2c levels. Protein
levels were analyzed by quantitative western blotting. Data were normalized to sham
irradiated values, which was set to 1. Data shown are means ± SEMs. (A) Summary
graph of MAP2c (Band 1) levels in hippocampal synaptosomes three and six months post
irradiation. (B) Representative immunoblots. *: P < 0.05 analyzed by Student's Mest
compared to control.
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NMD A receptor levels in the hippocampus are considerably associated with impairments
in learning and memory. Specifically, L-AP5, a NMDA receptor antagonist, blocks the
induction of LTP in the hippocampus and decreases spatial memory performance (130).
Also, knockout mice lacking the obligatory NR1 subunit exhibit impaired LTP and
spatial memory performance (131). Moreover, preferential inhibition of NR2A subunits
prevented the induction of LTP, and selective blocking of NR2B subunit abolished the
induction of LTD (73). Furthermore, we have detected severe reduction of the level of pi
adrenergic receptors, which also play a critical role in LTP induction (82). Thus, my
finding on HZE radiation induced reduction of these receptor levels provides a potential
link between HZE radiation and radiation-induced cognitive dysfunction.
In contrast, glutamatergic AMPA receptor levels were unchanged. This result is
consistent with a previous radiation research. Shi and co-workers found that 45 Gy of
Cs radiation, a dose for the treatment of brain tumors, induced significant alternation in
NMDA receptor, but not in AMPA receptors. The nature of this specificity is difficult to
discern from the present experiments, however, it is reported that NMDA possesses a
unique reduction-oxidation site and ROS oxidizes the sulfhydryl residues associated with
this site (132), which facilitates vulnerability of NMDA receptors to oxidative stress (64,
132). Twenty to fifty percent decreases in the density of NMDA receptors during aging
have been reported, probably due to age related oxidative stress (64). In accordance with
these reports, pi adrenergic receptor is also susceptible to oxidative stress (133), and the
level declines by pretreatment with H2O2 (134) and also with age (135). Consequently,
we presume the specificity of effects of HZE radiation on levels of neurotransmitter
receptors may associate with susceptibility of each receptor to oxidative stress.
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Levels of a scaffold protein, PSD-95, was not significantly altered after radiation
exposure. Thus, we speculate that the observed reduction in NMDA receptors did not
influence number or size of downstream postsynaptic contacts. The result is in line with
previous studies, which suggested relatively less functional association of PSD-95 with
NMDA receptors. Mice lacking PSD-95 show normal NMDA receptor clustering and
function, but reduced AMP A receptor function (136). In addition, over-expression of
PSD-95 did not influence NMDA receptor clustering, but enhanced AMPA receptor
recruitment in developing hippocampal neurons (137). It is likely that a predominant role
of PSD-95 may be to regulate AMPA receptor insertion and retention at the synapse,
therefore, that PSD-95 has the closer association with AMPA receptors. My finding of
unaltered levels of AMPA is consistent with this notion.
Questions still remain about the unaltered receptor levels 6 months post
irradiation. I speculate that a possible "repair mechanism" may take place after radiation
damage. Recovery of HZE radiation induced damage on dendritic spine was previously
reported, e.g. decrease in dendritic spine length of CA1 hippocampal neurons was less
severe after one year (65). My finding in MAP2c levels also supports the possible
recovery. Pronounced reduction in MAP2c level was found at 3 months post irradiation,
whereas the level was up-regulated 6 months post irradiation. MAP2 provides scaffolds
in dendrites and facilitates the localization of signal transduction apparatus there,
particularly near dendritic spines (127). The correlation with levels of NMDA NR1
subunit and MAP2c suggest some degree of dendritic spine recovery at 6 months. This
cellular process likely affected NMDA receptor sub-synaptic domains more specifically,
since levels of AMPA receptors, which are also localized to dendritic spines but within
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the distinct domains (138), were unaltered in our experiments.
My study on two synaptic vesicle markers assure that 0.6 Gy of 56Fe irradiation
did not affect synaptic vesicle stores in the hippocampus, thus, depletion of glutamate
stores or apoptotic damage of nerve terminals are unlikely to be a cause of reduction in
glutamatergic release observed in our experiments (Chapter II). In line with my results, a
previous study using a higher dose (2.0 Gy) of
levels

of

synaptophysin

in hippocampus

56

Fe radiation also reported unaltered

(139),

supporting

the

notion

that

neurotransmitter stores are not the direct locus of radiation-induced deficits.
Overall, my findings on reduced levels of glutamatergic NMD A and pi
adrenergic receptors, both of which are critical in synaptic plasticity and in learning and
memory, provide mechanistic evidence underlying HZE radiation induced cognitive
dysfunction.
Although there were overall changes in neurotransmitter release (Chapter II) and
neurotransmitter receptor levels by HZE irradiation, there were a number of differences.
Regarding the time course of the HZE effects, I observed persisting suppression of
evoked glutamate and GAB A release, but a recovery in NMD A and pi adrenergic
receptor levels. Also, while both glutamate and GABA release were suppressed, only the
NMDA type glutamate receptors changes, leaving GABA receptors unchanged.
Moreover, while NE release was not affected, pi adrenergic receptor levels were reduced
at 3 months post irradiation. These findings suggest that the effects of HZE radiation in
neurotransmitter release and neurotransmitter receptor levels are either completely
independent or subjected to complex interactions that may involve homeostatic regulation.
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CHAPTERVI
HZE RADIATION INDUCED LIPID PEROXIDATION

BACKGROUND
As we documented in Chapter II,

56

Fe radiation (0.6 Gy, 1 GeV/n)) induces

significant reduction in hippocampal neurotransmitter release. The results raised a
question on the integrity of cell membrane in the hippocampus after radiation exposure.
One important factor that affects the membrane integrity is lipid peroxidation, a
consequence of oxidative stress. Lipid peroxidation leads to disturbance of Ca
homeostasis that may affect functions of release machinery (discussed in Chapter II). To
test this possibility, I have measured levels of lipid peroxidation in the hippocampus three
and six months post irradiation.
Oxidative stress can be perceived as an imbalance of cellular pro-oxidant and
anti-oxidant processes, resulting in the generation of ROS. The brain by nature provides
favorable environments for generation of ROS (47). It consumes 20% of the oxygen
utilized by the body, although the brain itself comprises only 2% of the body weight.
Despite the high ratio of aerobic glycolysis, neurons contain relatively lower levels of
antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxidase
compared with other organs in the body (140). Moreover, the brain is exceptionally
vulnerable to lipid peroxidation, for neurons contain high levels of peroxidizable fatty
acids (141).
Ionizing radiation is capable of producing a variety of ROS (26, 27, 30). HZE
radiation is a type of high LET (linear energy transfer) radiation, and predominant effects
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involve direct ionization. Peroxide (H2O2) pretreatment have been used extensively to
study free radical chemistry of HZE radiation (28, 29, 142), whereas water radiolysis, in
which indirect effect of ionizing radiation leads to the formation of hydroxyl radicals
("OH), has been used to model low-LET type radiation such as X-rays (101).
H2O2 is a ROS, but it is a non-radical and is relatively unreactive. It is converted
to highly reactive 'OH in the presence of decompartmentalized Fe ions:
Fe2+

i
H 2 0 2 + e- -»

OH- + "OH

Because "OH is high reactive, its diffusion radius is only 0.3 nm (141). Diffusible H2O2
penetrates cell membranes, whose thickness is between 6 ran to 10 ran, and contributes to
a short-lived 'OH to be distributed both intra- and extracellularly. Thus, "OH is able to
contact oxidative targets of hydrophobic lipid tails in the cell membrane and becomes a
major source of lipid peroxidation products.
Treatment of a hippocampal slice with H2O2 altered electrophysiological
properties including decreased ability to generate action potentials (29). The treatment
also increased lipid peroxidation, raising the possibility that the electrophysiological
effects were mediated by a lipid peroxidation mechanism (30). In line with the finding,
H2O2 suppressed K+-stimulated

[3H]-glutamate release by 20% using cortical

synaptosomal preparation (31). Pretreatment with antioxidants including iron chelator
revealed that "OH, but not H2O2, was responsible for the observed effects (30). These
results suggested that impairments in hippocampal neurotransmission after HZE
irradiation may be mediated by lipid peroxidation.
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Previous studies using dichlorofluorescein (DCFH) assay showed that 1.5 Gy of
Fe radiation led to increased ROS production in the frontal cortex of rats one month
after exposure (139). Limoli and co-authors also demonstrated that a lower dose of 56Fe
radiation (< 1.0 Gy) could elicit significant increase in ROS production in hippocampal
precursor cells one month post irradiation (26). Another line of evidence showed that
whole body irradiation with 1.5 Gy of

56

Fe particles substantially augmented lipid

peroxidation in mice cerebellum one months post irradiation, and exposure also impaired
the reference memory (27). Although the above studies support a role for ROS
production and lipid peroxidation in HZE radiation induced brain damage, there are no
reports that directly correspond to our experimental conditions. Therefore, we have
estimated the levels of lipid peroxidation in the hippocampus three and six months post
0.6 Gy of 56Fe irradiation.
Lipid peroxidation is oxidative degradation of lipids (LH) by ROS (X"), such as
OH". Most often affected is the methylene group (-CH2-) in polyunsaturated fatty acids,
which possess reactive hydrogen to produce unstable lipid radical (L-);
1) LH + X' -> L' + XH

(Initiation)

Lipid radical readily reacts with O2 to produce lipid peroxyl radical (LOO");
2) L' + 0 2 -» • LOO"
Reaction can propagate, and eventually changes the membrane structure;
3) LOO" + LH -» LOOH + L"

(Propagation)

Hydroperoxides (LOOH) result in production of a series of new reactive species, e.g. 4hydroxyalkenals (HAE) and malondialdehyde (MDA);
4) LOOH -> short chain radicals, reactive aldehydes
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The radical chain continues to proceed, until it is terminated;
5) LOO' + LOO' -> non-radical product (Termination)
As this bimolecular scheme illustrates, LOO' possesses paradoxical abilities to serve in
both propagation and termination, which explains the inverse dose-response effect at
radiation induced lipid peroxidation {101, 143). The inverse dose-response means that
high production rates of free radiais, which initiate lipid peroxidation, yield a smaller
amount of reactive end products than low production rates. This is distinct from the doseresponse of radiation effects, where high dose is more effective than low dose. It is
noteworthy that these secondary reactive species such as L", LOO', as well as
degradation products of LOOH, are also capable to interact with lipids and membrane
proteins.
The alteration of membrane structures leads to increased membrane permeability.
Inactivation of ion channels and increase of unspecific membrane leak was found after
oxidative insult (101). These allow membrane depolarization (144) and non-specific Ca +
influx (145). An important pathophysiological consequence is disruption of Ca
homeostasis and alteration of neural transmission.
I assayed levels of MDA and HAE, end products of LOOH (Eq. 4).
Measurements of them have been used as an indicator of lipid peroxidation. As a result, I
have found that 0.6 Gy of

56

Fe radiation (1 GeV/n) induced high levels of lipid

peroxidation in the hippocampus three months post irradiation. The high levels persisted
six months post irradiation.
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MATERIALS AND METHODS
Sample Preparation
Hippocampus was dissected and stored at -80°C to prevent loss of MDA and HAE,
and to prevent further oxidation. Frozen samples were thawed on ice. Tissues from 4
animals were pooled, and then homogenized in ice-cold PBS containing 5 mM butylated
hydroxytoluene (BHT), an antioxidant, to prevent new lipid peroxidation during
homogenization. Homogenates were centrifuged at 3000 x g at 4°C for 10 min to pellet
cell debris. Aliquots of supernatant were taken to determine protein concentration using
the Coomassie Plus better Bradford assay kit (Pierce) according to manufacturer's
instructions. Protein concentration of samples was adjusted to 15 - 60 mg/ml. Samples
were kept on ice until use.
Lipid Peroxidation Assay
Measurement of MDA in combination with HAE was performed using a microplate assay kit (Oxford Biomedical Research, Oxford, MI) according to the
manufacturer's directions. The assay is based on a color reaction of a chromogenic
reagent, N-methyl-2-phenylindole, with MDA and HAE. One molecule of either MDA or
HAE reacts with 2-molecules of the reagent to yield a stable chromophore with
absorbance at 570 nm. Samples were added to the reagent, and incubated at 45°C for 60
min, followed by centrifugation at 15,000 x g for 10 min to obtain a supernatant clear
from precipitates. Values were expressed as MDA + HAE nmol/mg protein. Samples
were assayed in triplicate in each experiment. Each measurement was repeated at least
three times.
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Statistics
The results were analyzed by Student's /-test. Differences between means were
considered significant at P < 0.05.

RESULTS
Point six Gy of 56Fe radiation (1 GeV/rt) leads to a significant increase in lipid
peroxidation in the hippocampus three and six months post irradiation
My results showed that the level of MDA + HAE was about two times higher in
0.6 Gy irradiated samples than in the sham control animals (control: 1.8 ± 0.30 nmol/mg
protein; irradiated: 3.8 ± 0.82 nmol/mg protein, P < 0.05, Student's t-test,n = 4, Fig. 23.)
The effects persisted six months post irradiation (irradiated: 4.0 ± 0.48 nmol/mg protein,
P < 0.05, Student's /-test, n = 4, Fig. 23.)
The temporal correlation between lipid peroxidation and reduction in
hippocampal glutamate and GAB A transmitter release caused by 0.6 Gy of 56Fe radiation
raises the possibility of a causal relationship.

DISCUSSION
My

results

demonstrate

an

inverse

relationship

between

hippocampal

neurotransmitter release and level of lipid peroxidation in the hippocampus of animals
exposed to 0.6 Gy of

56

Fe radiation. These two phenomena correlated well and the

inverse relationship persisted even through 6 months. This delayed effect of oxidative
insults on membrane might be a contributing factor to the observed reduction of
hippocampal neurotransmission.
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FIG. 23. Point six Gy of 56Fe radiation (1 GeV/n) induced changes in products of lipid
peroxidation in the hippocampus. Levels of lipid peroxidation were evaluated as
described in the Materials and Methods. Briefly, hippocampal homogenate was loaded
with a chromogenic reagent, iV-methyl-2-phenylindole at 45°C for 60 min, and lipid
peroxidation was assessed by measuring the levels of MDA (malondialdehyde) in
combination with a derivative, HAE (4-hydroxyalkenals) at three months and six months
post irradiation. Values are expressed as means of MDA + HAE (nmol/mg protein) ±
SEM. Asterisks indicate statistical significance analyzed by two- tail Student's Mest. (n
= A).
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Radiation induced lipid peroxidation is a non-enzymatic random reaction (146),
but extremely common phenomena in the brain. It is noteworthy that this radiation
induced insult was one of a few uniform responses among irradiated subjects, based on a
long-term investigations after the Chernobyl nuclear accident (45). Generally, radiation
effects display high variability among subjects due to different radio-sensitivity of each
individual.
While previous studies focused on the early delayed effects of HZE radiation on
ROS production (147) and lipid peroxidation (27) detected one month post irradiation,
my results indicate that the effects can persist well beyond one month, for as long as 6
months, suggesting that production of ROS can be continuous and may play a critical role
in late delayed effects of HZE radiation on neurotransmission. Mechanistic explanation
of this prolonged membrane oxidization is beyond the scope of this study, however, it has
been suggested that paradoxical ability of reactive species, which both initiate and
terminate chain reaction that results in lipid peroxidation, might be relevant to prolonged
production (143). In order to terminate the chain of events, it is necessary to reduce lipid
hydroperoxides as well as to decompose concomitant formation of LOO". Consequently,
the role of endogenous antioxidants has received extensive attention. It is likely that an
optimal concentration of antioxidants may exist that will restore the free radical level to
yield the best combination of inhibition and termination to minimize net lipid
peroxidation, and any concentration other than this optimal leads to increased, thus,
prolonged lipid peroxidation (143).
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CHAPTER V
SUMMARY

The main findings of the present study were: 1) 0.6 Gy of

56

Fe radiation (1

GeV/n) significantly perturbed chemical neurotransmission of rat hippocampal nerve
terminals, resulting in a persisted reduction of hypertonic sucrose evoked [3H]-glutamate
and [14C]-GABA release; 2) exposure to 0.6 Gy of

56

Fe radiation also significantly

reduced levels of glutamatergic NMDA receptors as well as pi adrenergic receptors three
months post irradiation, however, partial repair may take place by six months post
irradiation; 3) the same radiation regimen significantly enhanced oxidative stress as
indicated by increased levels of lipid peroxidation products in the hippocampus both
three and six months post irradiation, suggesting that increased levels of lipid
peroxidation played an important role in reduction of neurotransmitter release.
Although it is presently untested whether these alterations within the
hippocampus directly contribute to aspects of radiation induced cognitive impairments,
our findings demonstrate that, after a single dose of 56Fe radiation as low as 0.6 Gy, the
neurochemical environment in the hippocampus becomes significantly altered, which
may underlie impairments in cognitive functions. It is of importance that synaptic
plasticity may be significantly altered via reduction of NMDA and pi adrenergic receptor
levels in the hippocampus.
Although precise mechanisms are still under debate, a generally accepted model
of radiation-induced cognitive dysfunction is depicted in Figure 24. In this classic
paradigm, neuronal cell death due to radiation induced generation of ROS leads to cell
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Classic Paradigm of Radiation-induced Cognitive Dysfunction
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FIG. 24. Classic paradigm of radiation-induced cognitive dysfunction. The solid
arrows indicate the generally accepted sequence of events from the absorption of
radiation to the expression of the various forms of biological damage, which
consequently leads to cognitive dysfunction. Dotted line indicates postulated
neurogenesis hypothesis (19, 36). Dashed line indicates a pathway proposed by the
present work.
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loss and/or tissue damage, which can deteriorate functions of the CNS (46). With high
dose radiation exposure, white matter necrosis is the dominant histopathological
presentation and consistently associated with demyelination (47). Demyelination impairs
the conduction of action potentials, and consequently impairs cognitive performance.
Whereas high doses of radiation produce overt histopathological changes, lower dose
exposures produce cognitive dysfunction without inducing obvious morphological
changes. Recently it was reported that radiation impaired

neurogenesis

via

neuroinflammatory process. Two Gy of 56Fe radiation reduced the rate of proliferation
among neuronal progenitors within the dentate gyrus, and also impaired hippocampus
dependent performance (19, 36). My findings with 0.6 Gy, which is regarded subthreshold for impairing neurogenesis, raise the possibility that HZE radiation could cause
functional

deficits

in

cognitive

behavior

without

involving

neurogenesis

or

histopathological changes as previously proposed (dashed line in Fig. 24).
Overall, this work contributes to Phase 1 of NASA Strategic Program Plan by 1)
uncovering a risk to the integrity of hippocampal chemical neurotransmission in the CNS,
and 2) collecting specific evidence for radiation induced alterations in synaptic functions
/ elements that are critical for normal cognitive functions.
In future studies, I would like to further extend my investigation to 1) validate
permissible exposure limits using a series of our assays. Also, assuming that lipid
peroxidation may at least partially underlie the observed reduction in neurotransmitter
release, optimized concentration of cellular antioxidants may rescue the radiation induced
deficits. Thus, the current assays would facilitate to: 4) develop effective mitigation
strategies. Pretreatment with RGS scavengers, such as polyethylene glycol-conjugated
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catalase (PEG-CAT), a cell permeable H2O2 scavenging enzyme, may reduce radiationinduced deficiencies. Also, diet antioxidants, such as vitamin E, are known to inhibit lipid
peroxidation and might ameliorate HZE radiation effects on neurotransmission.
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